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Abstract 39 
The stomach is inhabited by diverse microbial communities, co-existing in a dynamic balance. 40 
Long-term use of drugs such as Proton Pump Inhibitors (PPIs), or bacterial infection such as 41 
Helicobacter pylori, cause significant microbial alterations. Yet, studies revealing how the 42 
commensal bacteria re-organize, due to these perturbations of the gastric environment, are in 43 
early phase and rely principally on linear techniques for multivariate analysis. 44 
Here we disclose the importance of complementing linear dimensionality reduction techniques 45 
such as Principal Component Analysis and Multidimensional Scaling with nonlinear 46 
approaches to unveil hidden patterns that with linear approaches remain unseen. Then, we 47 
show the importance to complete multivariate pattern analysis with differential network 48 
analysis, to reveal mechanisms of re-organizations which emerge from microbial variations 49 
induced by a medical treatment (PPIs) or an infectious state (H. pylori). Finally, we reveal 50 
metabolomic network alterations associated to the perturbed microbial communities. 51 
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The gastric environment with its microbiota is the active gate that regulates access to the whole 58 
gastrointestinal tract, and therefore it has a remarkable impact on the correct functionality of 59 
the entire human organism. Recent studies have revealed that many orally administered drugs 60 
can perturb the elegant balance of the gastric microbiota 1,2. However, not all of them cause 61 
permanent adverse effects and particular attention should be addressed to drugs that are 62 
frequently prescribed and administered for long periods. They can cause permanent unbalance 63 
of the gastric microbiota that might generate adverse side effects for the patient’s health. Since 64 
the introduction of proton pump inhibitors (PPIs) into clinical practice more than 25 years ago, 65 
PPIs have become the mainstay in the treatment of gastric-acid-related diseases 3. PPIs are 66 
potent agents that block acid secretion by gastric parietal cells by binding covalently to and 67 
inhibiting the hydrogen/potassium (H+/K+)-ATPases (or proton pumps), and additionally they 68 
can bind non-gastric H+/K+-ATPases, both on human cells and on bacteria and fungi, such as 69 
Helicobacter pylori  (H. pylori)4–6. 70 
PPIs are drugs of first choice for peptic ulcers (PU) and their complications (e.g. bleeding), 71 
gastroesophageal reflux disease (GERD), nonsteroidal anti-inflammatory drug (NSAID)-72 
induced gastrointestinal (GI) lesions, Zollinger-Ellison syndrome and dyspepsia 3,7,8. In 73 
particular, dyspepsia is a common clinical problem characterized by symptoms (e.g. epigastric 74 
pain, burning, postprandial fullness, or early satiation) originating from the gastroduodenal 75 
region 9. The potent gastric-acid suppression drugs  PPIs can treat the most frequent causes of 76 
dyspepsia including GERD, medication-induced gastritis, and peptic ulcers, thus minimizing 77 
the need for costly and invasive testing, and moreover are currently recommended to eradicate 78 
H. pylori infection, in combination to antibiotics 7,9,10. Nevertheless, some patients are resistant 79 
or partial responders to empiric PPI therapy, and continue to have dyspepsia 7.  80 
Additionally, there is growing evidence that these medications are associated with increased 81 
rates of pharyngitis and upper and lower respiratory tract infections 11. Their long-term 82 
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overutilization has been associated with potential adverse effects. For instance: the 83 
development of corpus predominant atrophic gastritis in H. pylori positive patients (that is a 84 
precursor of gastric cancer), enteric infections (especially Clostridium difficile-associated 85 
diarrhoea), increased risk of fundic gland polyps, hypomagnesaemia and hypocalcaemia, 86 
osteoporosis and bone fractures, vitamin and mineral deficiency, pneumonia, acute interstitial 87 
nephritis, and increased risk of drug–drug interactions, among others 7,12–15.  88 
Consumption of such acid-suppressive medications has also been associated with changes in 89 
microbial composition and function of gut microbiota. More recent studies relying on amplicon-90 
based metagenomic approaches, have shown that PPIs exert an effect on gastric, oropharyngeal, 91 
and lung microflora in children with a chronic cough 11,  and have a significant impact on the 92 
gut microbiome in healthy subjects, with an increase of oral and pharyngeal bacteria and 93 
potential pathogenic bacteria 16,17. Furthermore, another study by Tsuda et al. 18 revealed that 94 
PPIs influence the bacterial composition of saliva, gastric fluid and stool in a cohort of adult 95 
dyspeptic patients. However, this latter study highlights how the influence of PPI administration 96 
on the fecal and gastric luminal microbiota is still controversial and further investigation is 97 
required to understand the interaction between PPIs and non-H. pylori bacteria. Hence, this 98 
represents the first reason that motivates the present study. 99 
In fact, by irreversibly blocking H+/K+-ATPases, PPIs inhibit gastric acid secretion by gastric 100 
parietal cells, which results in a higher intragastric pH, meaning the microenvironment of this 101 
niche changes, hence allowing more bacteria to survive the gastric acid barrier 4,5,16. The use of 102 
PPIs and higher gastric pH were indeed correlated with the overgrowth of non-H. pylori 103 
bacterial microflora in the stomach of patients with gastric-reflux and PPIs were shown to 104 
aggravate gastritis because of co-infection with H. pylori and non–H. pylori bacterial species 105 
4,14,19,20. However, PPIs may also affect the gastrointestinal microbiome through pH-106 
independent mechanisms, by directly targeting the proton pumps of naturally occurring bacteria 107 
by binding P-type ATPases (e.g. H. pylori) 4,6.  108 
5 
 
Attempts to detect patterns of PPI related gastrointestinal changes have been made in different 109 
studies 21,22 through linear multidimensional analysis techniques, such as Principal Component 110 
Analysis (PCA) and Multidimensional Scaling (MDS), also called  Principal Coordinates 111 
Analysis (PCoA). Nevertheless, they failed to detect the effect of PPIs on gastric fluid samples 112 
21, nor any significant PPI-related modification in esophageal 21 and gastric 22 tissue samples. 113 
This represents the second reason that motivates our investigation. Are these controversial 114 
results due to complex patterns that cannot be detected using linear analysis? 115 
In this study, we show an unprecedented result: unlike linear approaches, Minimum Curvilinear 116 
Embedding (MCE) 23, which is a technique for nonlinear dimension reduction, discriminated 117 
both the esophageal and the gastric tissue microbial profiles of patients taking PPI medications 118 
from untreated ones when re-analyzing the data published in the abovementioned studies. This 119 
finding demonstrates the importance of routinely integrating the use of nonlinear 120 
multidimensional techniques into clinical metagenomic studies, since addressing nonlinearity 121 
could significantly modify the results and conclusions. Indeed, the absence of separation by 122 
means of linear transformations does not imply absence of separation in general, and nonlinear 123 
techniques could prove it, especially in complex datasets such as the ones generated in 124 
metagenomics 16S rRNA. As a matter of fact, the high throughput profiling of bacteria is 125 
frequently used in clinical studies, thus posing a challenge to efficient information retrieval: 126 
understanding how microbial community structure affects health and disease can indeed 127 
contribute to better diagnosis, prevention, and treatment of human pathologies 24.  128 
The common practice in unsupervised dimension reduction data analysis is to consider only the 129 
first two (or three, less used) dimensions of mapping, and the goal is to visually explore  the 130 
distribution of the samples and the incidence of significant patterns 25. This type of analysis is 131 
advantageous to validate hypothesis or to generate new ones. In addition, this procedure is 132 
particularly useful in case of studies with small size datasets 23, or for imbalance class 133 
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samples, to obtain unbiased (the labels are not used) confirmation of the separation between 134 
groups of samples for which diversity is theorized or expected. 135 
In addition, we will provide an analysis with two nonlinear algorithms for dimensionality 136 
reduction often used in literature, namely Isomap 26 and t-SNE 27,28. These methods, 137 
although unsupervised, need hyperparameters optimization. Indeed, Isomap needs as 138 
input a parameter related to ‘k’ number of neighbours to construct a network, whereas 139 
t-SNE needs the perplexity and number of dimensions (or components). Different values 140 
of these parameters may lead to different results, which represent a challenge in an 141 
unsupervised scenario where automatic and label-free selection of the best solution is 142 
wished. This is the reason why this study will focus mainly on parameter-free 143 
dimensionality reduction techniques, whereas Isomap and t-SNE results will be shortly 144 
considered for a specific dataset in the result section. 145 
Here, we will specifically analyse the many aforementioned 16S rRNA amplicons datasets to 146 
address the following pattern recognition questions: (1) Is PPI treatment affecting change on 147 
the microbiota of esophageal and gastric tissues in dyspeptic patients, regardless of the initial 148 
pathological infection due to H. pylori? (2) Is this PPI-induced change so dominant as to result 149 
in a discernible pattern in the first two dimensions of mapping by unsupervised dimension 150 
reduction? (3) Are linear techniques sufficient to bring out patterns in complex microbial data?  151 
Furthermore, using differential network analysis we will address from the systems point of view 152 
these other questions: (4) How is PPI affecting the microbiota in the gastric environment in 153 
dyspeptic patients?  (5) What is the effect of H. pylori infection on gastric mucosal microflora? 154 
Both factors (PPI treatment and H. pylori infection) can influence the composition of the gastric 155 
microbiota, and this further analysis will help to understand the general (overall) behaviour of 156 
the microbial ecosystem under these conditions. Ultimately, this means that we will try to 157 
clarify and visualize via network representation how the bacterial cooperative organization is 158 
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systemically altered either by the use of this acid suppressant drug in the gastric environment 159 
under dyspepsia, or by H. pylori infection in the gastric mucosa. 160 
 161 
Methods 162 
Dataset description 163 
Amir3 (esophageal mucosa) 164 
The 16S rRNA gene sequences were generated by Amir and colleagues 21 and are publicly 165 
available via the MG RAST database  (http://metagenomics.anl.gov/linkin.cgi?project=5767).  166 
The dataset was obtained from 16 esophageal mucosal biopsies of eight individuals before and 167 
after eight weeks of PPI treatment. Two patients with heartburn presented normal 168 
oesophagogastroduodenoscopy (H) indicating that they present healthy oesophageal tissues but 169 
are exposed to gastric refluxate, four patients had oesophagitis (ES) and two had Barrett's 170 
oesophagus (BE). Metagenomics data were obtained by pyrosequencing 16S rRNA gene 171 
amplicons on the GS FLX system (Roche). Data were processed by replicating the 172 
bioinformatics workflow followed by Amir and colleagues 21 in order to obtain the matrix of 173 
the bacterial absolute abundance: sequence reads were analysed with the pipeline Quantitative 174 
Insights into Microbial Ecology (QIIME) v. 1.6.0 29 using default parameters (sequences were 175 
removed if shorter than 200 nt, if they contained ambiguous bases or uncorrectable barcodes, 176 
or if the primer was missing). Operational Taxonomic Units (OTUs), that are clusters of 177 
sequences showing a pairwise similarity no lesser than 97%, were identified using the UCLUST 178 
algorithm (http://www.drive5.com/usearch/). The most abundant sequence in each cluster was 179 
chosen as the representative of its OTU, and this representative set of sequences was then used 180 
for taxonomy assignment by means of the Bayesian Ribosomal Database Project classifier 30 181 
and aligned with PyNAST103. Chimeras, that are PCR artefacts, were identified using 182 
ChimeraSlayer 31 and removed. The Greengenes database, which was used for the annotation 183 
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of the reads, additionally identifies groups of bacteria that are supported by whole genome 184 
phylogeny, but are not yet officially recognized by the Bergeys taxonomy, which is the 185 
reference taxonomy and is based on physiochemical and morphological traits. This results in a 186 
special annotation for some taxa, like Prevotella, that thus appears both with the general 187 
annotation, that is Prevotella, and with the special annotation, that is between square brackets, 188 
[Prevotella]. 189 
 190 
Amir4 (gastric fluid) 191 
The dataset was generated by Amir and colleagues 21, and is public and available in the MG 192 
RAST database (http://metagenomics.anl.gov/linkin.cgi?project=5732). It comprises eight 193 
patients, whose gastric fluid was sampled at two different time points, that is before PPI 194 
treatment and after eight weeks of PPI treatment, for a total of 16 samples. The patients are the 195 
same described in Amir3. Metagenomics data were obtained by pyrosequencing fragments of 196 
the 16S rRNA gene amplicons on the GS FLX system (Roche). Then the data were processed 197 
by replicating the same bioinformatics workflow  followed by Amir and colleagues 21 that was 198 
described in the previous data description (Amir3), in order to obtain the matrix of the bacterial 199 
absolute abundance. As for Amir3, the Greengenes database was used for the annotation of the 200 
reads. 201 
 202 
Paroni Sterbini (gastric mucosa) 203 
The dataset was generated by Paroni Sterbini and colleagues 22, and is public and available in 204 
the NCBI Sequence Read Archive (SRA) (http://www.ncbi.nlm.nih.gov/sra, accession number 205 
SRP060417), where all details pertaining the sequencing experimental design are also reported. 206 
It contains 24 biopsy specimens of the gastric antrum from 24 individuals who were referred to 207 
the Department of Gastroenterology of Gemelli Hospital (Rome) with dyspepsia symptoms (i.e. 208 
heartburn, nausea, epigastric pain and discomfort, bloating, and regurgitation). Twelve of these 209 
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individuals (PPI1 to PPI12) had been taking PPIs for at least 12 months, while the others (S1 210 
to S12) were not being treated (naïve) or had stopped treatment at least 12 months before sample 211 
collection. In addition, 9 (5 treated and 4 untreated) were positive for H. pylori infection, where 212 
H. pylori positivity or negativity was determined by histology and rapid urease tests. 213 
Metagenomics data were obtained by pyrosequencing fragments of the 16S rRNA gene 214 
amplicons on the GS Junior platform (454 Life Sciences, Roche Diagnostics). Then the 215 
sequence data were processed by replicating the bioinformatics workflow followed by Paroni 216 
Sterbini et al. 22, in order to obtain the matrix of the bacterial absolute abundance. 217 
 218 
Parsons (gastric mucosa) 219 
The dataset was generated by Parsons and colleagues 32, and is public and available in the EBI 220 
short-read archive (the European Nucleotide Archive, ENA) (https://www.ebi.ac.uk/ena, 221 
accession number PRJEB21104). In the original study, the authors focused on the analysis of 222 
gastric biopsy samples of 95 individuals (in groups representing normal stomach, PPI treated, 223 
H. pylori-induced gastritis, H. pylori-induced atrophic gastritis and autoimmune atrophic 224 
gastritis), selected from a larger prospectively recruited cohort patients who underwent 225 
diagnostic upper gastrointestinal endoscopy at Royal Liverpool University Hospital32. RNA 226 
extracted from gastric corpus biopsies was analysed using 16S rRNA sequencing (MiSeq). 227 
Then the sequence analysis was performed, as described by the authors in the supplementary 228 
methods of the original article 32. Here we focused on the analysis of gastric biopsy specimens 229 
(in total 42 samples) from normal stomach group (20 patients) and belonging to the H. pylori 230 
gastritis group (22 patients). As described in 32, patients in the normal stomach group showed 231 
normal endoscopy, no evidence of H. pylori infection by histology, rapid urease test or serology, 232 
were not treated by PPI and were normogastrinaemic. Patients in the H. pylori gastritis group 233 
were instead positive to H. pylori infection by urease test, histology and serology, were not 234 




Data exploration and visualization: the reason for unsupervised dimension 237 
reduction  238 
The main reason to perform an unsupervised dimension reduction is to explore and visualize 239 
the most relevant sample patterns that should emerge in the first two dimensions of embedding 240 
(which represent the information of higher variability in the data) from the hidden 241 
multidimensional space of a dataset. The fact that the sample labels (if known) are not used for 242 
the data projection makes the analysis unsupervised. The advantage of performing an 243 
unsupervised analysis is both for data quality checking and to gather the main trends hidden in 244 
the data, independently from any hypothesis or knowledge available on the samples. This is 245 
particularly useful to discover the presence of interesting sub-groups inside the studied cohort 246 
or to detect the influence of confounding factors.  247 
A final interesting advantage offered by unsupervised analysis is in small size datasets, where 248 
the number of samples n is significantly lower that the number of features p, a condition that 249 
unfortunately occurs in several metagenomic studies. When n<<p the application of supervised 250 
approaches can become problematic, because the supervised procedure of parameter learning 251 
can suffer from overfitting 23,33,34. 252 
The mainstream multivariate methods to unsupervisedly explore data patterns in metagenomic 253 
studies are based on linear dimension reduction, in particular PCA 35,36 and MDS 37,38, also 254 
known as PCoA, methods that have been used to explore and visualize data structure in many 255 
metagenomic studies, from sponge 39,40 to gastric tissue microbiota 22. These tools perform a 256 
dimension reduction of the data either by multidimensional variance analysis (for instance 257 
PCA) or dissimilarity embedding (for instance MDS/PCoA). PCA collects uncorrelated 258 
variance in the multidimensional space, creating new synthetic orthogonal variables, which are 259 
linear combinations of the original ones, then plots the samples in a reduced space using the 260 
new variables that embody the largest orthogonal variances. MDS computes dissimilarities 261 
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between every pair of samples, plotting the Euclidean part of these dissimilarities as distances 262 
between every pair of points (MDS) in a reduced space, in this way the linear part of the sample 263 
relations can be represented.  264 
 265 
PCA, MDS (or PCoA) and LDA 266 
Below, we report some of the PCA major advantages and drawbacks, that were pinpointed in a 267 
recent study on multidimensional population genomics 41, and of other conventional 268 
dimensional reduction techniques employed for the analysis of metagenomic data.  269 
PCA is time-efficient, parameter-free and straightforward to interpret, yet it strives to resolve 270 
structure in datasets with few samples and highly numerous features, which enclose nonlinear 271 
patterns. Therefore, PCA can occasionally fail to reveal differences among samples, even when 272 
differences are known a-priori, which means it can also miss represent hidden nonlinear 273 
relations among the samples in the feature space. For instance, see the illustration of the PCA 274 
two-dimension reduction mapping of the Tripartite-Swiss-Roll dataset in Suppl. Fig. S1B. PCA 275 
clearly fails to unfold and reveal the structure of the three separated groups of samples.   276 
MDS, on the other hand, preserves the sample distances in a 2D-space based on the calculation 277 
of a distance matrix (Suppl. Fig. S1C,D). In ecology, distance (or dissimilarity) matrices are a 278 
major way to transpose the ecological information of samples in terms of their species 279 
composition and abundance 42,43. In this article we will consider classical MDS (which uses 280 
Euclidean distance and is in practice equivalent to PCA 44,45), and non-metric MDS (NMDS) 281 
obtained according to Sammon’s Mapping 46. In the latter, the elements of the multivariate 282 
space are mapped onto a lower dimensional space while retaining the original inter-point 283 
dissimilarities, by means of a nonlinear, but monotonic transformation (Sammon Mapping). 284 
Since it respects the ranking of dissimilarities, it tends to linearize the relationships between the 285 
samples. In addition, MDS will be performed also according to Bray-Curtis (MDSbc) 286 
dissimilarity and weighted UniFrac (MDSwUF) distance because they are considered the 287 
12 
 
reference in metagenomics studies. Bray-Curtis dissimilarity quantifies how dissimilar two sites 288 
(samples) are based on counts (bacterial abundances), where 0 means two samples are identical 289 
and 1 means that the two samples do not share any taxa 47,48. Dissimilarly, the UniFrac distance, 290 
either unweighted (qualitative) or weighted (quantitative), is the most popular phylogenetic 291 
distance measure for the microbial community diversity between different samples (also known 292 
as β-diversity 49) and, differently from the previous discussed methods, uses the phylogenetic 293 
information (which is an external knowledge not contained in the dataset) on the taxa to 294 
compare samples. In particular, its weighted-version weights the branches of a phylogenetic 295 
tree based of the taxa abundance information 50–53. Hence the weighted UniFrac distance 296 
directly accounts for differences in the abundance of different kinds of bacteria, and can be 297 
crucial to describe community changes 51 in the studied samples.  298 
We need to specify that both MDSwUF and NMDS are in practice nonlinear methods and 299 
weighted UniFrac is not a classical unsupervised technique like the others. In fact, MDSwUF 300 
adopts a distance that combines the information given by the bacterial abundance of the dataset 301 
with the supervised prior (external) knowledge regarding the known hierarchical phylogenetic 302 
relationship among the bacteria. However, like PCA, MDS can fail to detect patterns if data are 303 
not properly linearized 54. For instance, see Suppl. Fig. S1C-D where MDSbc and NMDS 304 
respectively fail to resolve the Tripartite-Swiss-Roll dataset. When we consider clinical 16S 305 
rRNA amplicons data, this failure potentially reduces the chances of correctly pinpointing 306 
samples which may represent clinical subspecies, and thus remain undetected and undiagnosed. 307 
In brief, these methods are not efficient to perform hierarchical embedding directly from the 308 
abundance value, since hierarchies preserve tree-like structures, and tree-like structures follow 309 
a hyperbolic, thus nonlinear, geometry 55–57. Only MDSwUF is able to account for nonlinear 310 
hierarchical organization, yet this is not directly inferred from the abundance values, but rather 311 
forced as a constraint of prior supervised knowledge on the phylogeny of bacteria. For this 312 
reason we cannot offer a test on the Tripartite-Swiss-Roll dataset. 313 
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In our analysis of the Paroni Sterbini dataset, we also showed the results of a supervised 314 
technique, Linear Discriminant Analysis (LDA), which uses the labels to perform dimension 315 
reduction. LDA aims to separate the samples into groups based on hyperplanes and describe 316 
the differences between groups by a linear classification criterion that identifies decision 317 
boundaries between groups 37. This technique is not congruous (and sometimes statistically 318 
invalid) for small sample size datasets. The reason is that given the reduced sample size we 319 
cannot divide the dataset in a training and test set, which is a fundamental requirement of 320 
supervised methods such as LDA. 321 
 322 
Minimum Curvilienar Embedding (MCE) 323 
In 2010, Cannistraci et al. 23 introduced the centred version of Minimum Curvilinear 324 
Embedding (MCE), which provided notable results in: i) visualisation and discrimination of 325 
pain patients in peripheral neuropathy, and the germ-layer characterisation of human organ 326 
tissues 23; ii) discrimination of microbiota in sea sponges 39; iii) embedding of networks in the 327 
hyperbolic space 56; iv) stage identification of embryonic stem cell differentiation based on 328 
genome-wide expression data 58. In this fourth example, MCE performance ranked first on 12 329 
different tested approaches (evaluated on 10 diverse datasets). More recently in 2013 33, the 330 
non-centred version of the algorithm, named ncMCE, has been used: i) to visualise clusters of 331 
ultra-conserved regions of DNA across eukaryotic species 59 ; ii) as a network embedding 332 
technique for predicting links in protein interaction networks 33, outperforming several other 333 
link prediction techniques; iii) to unsupervisedly reveal hidden patterns related with gender 334 
difference and metabolic-disease risk-factors in lipidomic profiles extracted from human 335 
plasma samples 60; iv) to unsupervisedly infer and visualize phylogenetic (hierarchical) 336 
relations directly from individual SNP profiles in human population genetics 41. Finally, also 337 
applications in non-biological problems such as the unsupervised discrimination of bad from 338 
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good radar signals 33, represented a proof of concept of the universality of MCE for addressing 339 
nonlinear investigation of data and signals in general. Also in the case of the metagenomics 340 
studies targeting sea sponges, 39,40, both MCE and its non-centred variant 23,33 once again proved 341 
successful in detecting structure where PCA and MDS could not, or hardly find any. This is 342 
mainly because MCE/ncMCE are unsupervised and parameter-free topological machine 343 
learning for nonlinear dimensionality reduction and multivariate analysis, that are able to 344 
perform a hierarchical embedding.  345 
This study stems from the intuition that MCE/ncMCE analysis could successfully reveal 346 
undetected patterns also in esophageal and gastric metagenomics data, where only unsupervised 347 
linear methods or classical nonlinear methods such as NMDS and MDSwUF had been used and 348 
had failed to achieve any clear-cut result 21,22. 349 
Minimum Curvilinearity (MC) 23, the principle behind MCE and ncMCE, was invented with 350 
the aim to reveal nonlinear data structures also, and especially, in the case of datasets with few 351 
samples and many features. MC principle suggests that curvilinear (nonlinear) distances 352 
between samples may be estimated as pairwise distances over their Minimum Spanning Tree 353 
(MST), constructed according to a selected distance (Euclidean, correlation-based, etc.) in a 354 
multidimensional feature space (here the metagenomic data space). In this study, we considered 355 
Pearson-correlation based distance (refer to 23 for details on the way to compute the distance 356 
for the MST). The collection of all nonlinear pairwise distances forms a distance matrix called 357 
the MC-distance matrix or MC-kernel, which can be used as an input in algorithms for 358 
dimensionality reduction, clustering, classification and generally in any type of machine 359 
learning. In MCE and ncMCE, the MC-kernel (which is non-centred for ncMCE) is followed 360 
by dimensionality reduction using singular value decomposition (SVD), and then by the 361 
projection of the samples onto a two-dimensional space for visualisation and analysis. Thus, 362 
MCE/ncMCE is a form of nonlinear and parameter-free kernel PCA 33. In the rest of the article 363 
we will simply use the name MCE to indicate both MCE and ncMCE, since the centring 364 
15 
 
transformation is related to the specific data pre-processing and will be specified for each 365 
dataset as a technical detail in the respective results’ tables.  366 
 367 
MCE to unsupervisedly infer and visualize phylogenetic (hierarchical) relations 368 
A previous study by Alanis-Lobato et al. 41 showed that MCE is automatically able to 369 
unsupervisedly infer and visualize phylogenetic (hierarchical) relations directly from individual 370 
SNP profiles in human population genetics. Precisely, ncMCE detected separation between 371 
ethnic groups and provided an ordering over the discriminating dimension that was related to 372 
the phylogenetic organization of these populations. 373 
This ability of MCE to infer and visualize phylogenetic (hierarchical) relationships was 374 
confirmed in our study on the Paroni Sterbini et al. dataset 22 (see Results section-‘ Gastric 375 
tissue dataset unsupervised analysis’). As previously mentioned (see the previous section 376 
‘PCA, MDS (or PCoA) and LDA’), MDSwUF uses a weighted Unifrac distance that combines 377 
the prior knowledge of the bacterial phylogenetic tree with the information given by the 378 
bacterial abundance. Here we show that MCE perform better than MDSwUF on the Paroni 379 
Sterbini et al. dataset, due to its ability to infer the (hierarchical) phylogenetic relationship 380 
among the bacteria directly from the bacterial abundance of the dataset, by performing a 381 
hierarchical embedding. Hence, MCE can be used to compare the composition of microbial 382 
communities in the studied samples, where the phylogenetic information is instead directly 383 
inferred from bacterial abundance, differently from MDSwUF. 384 
 385 
Procedure to evaluate the performance of the dimension reduction algorithms 386 
The performance of the mentioned dimension reduction algorithms is evaluated as the ability 387 
to separate the samples in the first two dimensions of embedding since, as discussed above, 388 
they are related with the treatment/infection response. In order to quantitatively evaluate 389 
the performance, we use a recently proposed index termed Projection Separability Index 390 
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(PSI) used for sample separation 61. This index can be defined for any separation-measure and 391 
in this study we considered well-known measures: Area Under the ROC-Curve (PSI-ROC) and 392 
Area Under the Precision-Recall curve (PSI-PR), that are regularly used to quantitatively 393 
measure the performance of a binary predictor.  394 
More precisely, in the 2D space a line is drawn between the centroids of the two groups that are 395 
compared, subsequently all the points are projected on this line and then AUC and AUPR are 396 
computed for the projected points. This new index can actually be applied not only in a 2D 397 
space, but in any N dimensional space. For the calculation of the centroids we consider the 2D-398 
median of each cluster/class’s group. In case more than two groups are present in a dataset, all 399 
the AUC and AUPR values between the possible pair-groups are computed. Then, the 400 
following formula is applied: E/(1+ 𝛿), where E is the mean of the pairwise PSI values and 401 
𝛿 their standard deviation. Thus, the standard deviation works as a penalization in case 402 
of outliers PSI values, ensuring that the overall PSI is high only when all pairwise PSI 403 
values are close to the mean.  The computed values are finally chosen as an overall estimator 404 
of separation between the groups in the 2D reduced space. This case applies only to the Paroni 405 
Sterbini dataset, which is composed of three or, possibly, four groups of samples. All the other 406 
datasets are instead composed of two groups.  407 
It is important to note that the PSIs were also applied to the data in the original high-408 
dimensional (HD) space, as a reference to see how good the unsupervised dimension reduction 409 
approaches are in preserving the original group separability of the HD space. 410 
All the algorithms were tested considering (when allowed by the dimension reduction method) 411 
data centring or non-centring. In addition, multiple normalization options were investigated and 412 
the datasets were considered under a certain type of normalization: division by the column - 413 
which reports the OTU - sum (indicated by DCS); division by the row – which reports the 414 




In order to verify that the performances obtained by our evaluations using PSI on the DR 417 
techniques are not obtained by chance, we calculate a measure termed trustworthiness, 418 
which exploits a resampling technique based on label-reshuffling to build a null model 419 
(Suppl. Fig. S2). The labels are reshuffled uniformly at random on the embedded points 420 
whose location is maintained unaltered in the reduced space. For each random reshuffling 421 
(the total number of reshuffling is a resampling parameter decided by the user, we 422 
adopted 1000 realizations), a PSI measure value is computed. The collection of all these 423 
values is used to draw the null model distribution. This distribution is employed to 424 
compute the probability to get at random a separation equal or higher than the one 425 
detected by using the original labels. 426 
 427 
From Markov Clustering (MCL) to Minimum Curvilinear Markov Clustering 428 
(MC-MCL) 429 
MCL is an unsupervised algorithm for the clustering of weighted graphs based on simulations 430 
of (stochastic) flow in graphs 62 (http://micans.org/mcl/). By varying a single parameter called 431 
inflation (with values between 1.1 and 10), clustering patterns on different scales of granularity 432 
can be detected. For clustering samples of a multidimensional dataset, the workflow starts with 433 
the computation of correlations (generally Pearson correlations) between the samples, and 434 
creates an edge between each pair of samples, where the edge-weight assumes the value of the 435 
respective pairwise positive sample correlation, or values zeros in case of negative correlations. 436 
This generates a weighted correlation graph (network), which is used as a map to simulate 437 
stochastic flows and detect the structural organization of clusters in the graph.  438 
With the purpose of creating and testing a nonlinear variant of the MCL algorithm, we adopt 439 
an innovative algorithm which was recently proposed and called MC-MCL 63. The idea is the 440 
following. The MC-kernel – discussed above in the MCE section - is a nonlinear distance matrix 441 
(or kernel) that expresses the pairwise relations between samples as a value of distance: small 442 
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samples distance indicates sample similarity, while large samples distance indicates sample 443 
dissimilarity. Here we reverse (using the following function:  𝑓(𝑥) = 1 − 𝑥) and after this we 444 
put to zero the negative values - strategy already applied in the original MCL algorithm - 445 
of the MC-distance kernel to get a MC-similarity kernel, where small values (close to zero) 446 
indicate low sample similarity and large values (close to one) indicate high sample similarity. 447 
A technical detail: for the computation of the MC-distance kernel, it is necessary to firstly 448 
square root the original distances (correlation-based) between the samples. As already 449 
investigated in 23, this attenuates the estimation of large distances and amplifies the estimation 450 
of short distances; consequently it helps to regularize the nonlinear distances inferred over the 451 
MST in order to subsequently use them for message passing 23 (such as affinity propagation) or 452 
flow simulation (such as MCL) clustering algorithms. 453 
Then, the standard stochastic flow simulations of MCL algorithm runs on the graph weighted 454 
with the values of the MC-similarity kernel (which collects pairwise nonlinear associations 455 
between samples) instead of the Pearson-correlation kernel (which collects pairwise linear 456 
associations between samples). In practice, this is a new algorithm for clustering that is a 457 
nonlinear version (based on the MC-kernel) of the classical MCL. The goal of the MC-MCL 458 
analysis is to verify whether the use of the MC-kernel improves performance, by solving 459 
nonlinearity, not only in dimension reduction (such as in MCE) but also in clustering (such as 460 
in MC-MCL).  461 
 462 
Procedure to evaluate the performance of clustering algorithms 463 
The clustering algorithms MCL and MC-MCL were applied to the datasets, either raw, or after 464 
the same normalization procedures used before dimensionality reduction (DCS: division by 465 
column (OTU) sum; DRS: division by row (sample) sum; LOG: function log10(1+x) applied 466 
to the dataset) and their performance was evaluated by means of accuracy. The accuracy is 467 
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computed as the ratio of the number of samples assigned to the correct clusters over the total 468 
number of samples. For both MCL and MC-MCL, we tested Pearson and Spearman correlations 469 
to build the similarity measure to feed into the clustering methods. The Spearman correlation 470 
can also detect a subclass of nonlinear associations (which have monotonic shape function) or 471 
correct for outliers. Differently from what suggested for large gene datasets with thousands of 472 
samples in 62 (http://micans.org/mcl/), in this study we had to consider the whole set of original 473 
positive correlations without applying any threshold (cut-off) to the values. This was 474 
compulsory, since we considered datasets with few samples. In our case, to keep the graph 475 
connected, with one unique connected component, we could not introduce any kind of threshold 476 
that would otherwise alter the real graph connectivity (dividing the graph in disconnected 477 
components) and hence the clustering result. Since the MCL algorithm needs a single input 478 
parameter (inflation) to control the granularity of the output clustering, we ran it for different 479 
inflation values until we achieved the desired number of clusters. Finally, in the Paroni Sterbini 480 
et al. dataset 22 it was not clear in advance whether the correct number of clusters present in the 481 
multidimensional space was three or four. Hence, we tested the clustering algorithms 482 
considering as output both three and four clusters’ configurations, and we identified as the best 483 
solution the one that offered the highest accuracy.  484 
 485 
PC-corr network 486 
Furthermore, we investigated the effect of PPI on the microbiota of gastric fluid and gastric 487 
mucosa in dyspeptic patients, and the changes induced by H. pylori infection on the gastric 488 
mucosal microbiota, by means of the PC-corr approach 64. PC-corr represents a simple 489 
algorithm that associates to any PCA segregation a discriminative network of features’ 490 
interactions 64. It is a method for linear multivariate-discriminative correlation network reverse 491 
engineering, that, thanks to its multivariate nature, can help to stress and squeeze out the 492 
underlying combinatorial and multifactorial mechanisms that generate the differences between 493 
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the studied conditions 64. Said what PC-corr is able to do, now we offer an intuitive 494 
explanation of how it works. PCA is one of the most employed approaches to 495 
unsupervisedly map linear dissimilarities (hidden in the high-dimensional space) into a 496 
visible space of data representation. When we notice that two or more groups of samples 497 
are separated along one of the axes of this representation space, generally the first 498 
question is to discover what are the features that are contributing more to this separation. 499 
This is easily achievable by analysing the PCA loading values that are associated to the 500 
axis along which emerges the sample separation under investigation. But the loading 501 
values do not provide any information on how those features mutually interact. On the 502 
other hand, a correlation network between the features provide information on their 503 
associative relation but not on their contribution to the discrimination. PC-corr is an 504 
algorithm that is able to integrate together the discriminative information of the loadings 505 
with the combinatorial information of the correlations. Indeed, PC-corr offers as output 506 
a discriminative correlation network of features that can help to elucidate the possible 507 
associative mechanisms that are at support of the sample separation along a specific axis 508 
of PCA representation. Hence, for the studied datasets, it can be employed to point out the 509 
possible presence of bacterial alterations and their interplay, induced by a medical treatment 510 
(PPIs in dyspepsia) or infectious state (H. pylori).  511 
Bacteria-metabolite multilayer network construction and metabolite pathway 512 
analysis 513 
We used a recently realized bacteria-metabolite bipartite network which is an open access 514 
resource 65 to infer the metabolic activity of the bacteria presented in the intersections of 515 
figures 6 and 7. The study 65 provided a large set of 9136 bacteria to metabolite 516 
interactions validated on experimental studies from mouse and human gastroenteric 517 
microbiota. It was available as a network, named NJC19, where node represented either 518 
bacteria or metabolites connected by several types of edges (e.g. production, consumption, 519 
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degradation). In this dataset we restricted the analysis to interactions found on human 520 
bacteria. Since the dataset identified bacteria according to the taxonomic levels of species 521 
while our data referred to the genus level, we made a new form of the NJC19 network 522 
with edges starting from the bacteria genus to metabolites. When we did not find any 523 
interactions for specific bacteria, we discarded them from further analyses. Therefore, 524 
from the list of intersected bacteria from figure 6 (Porphyromonas, Capnocytophaga, 525 
Streptophyta, Granulicatella, Clostridiales, Oribacterium, Veillonella, Bulleidia, 526 
Fusobacterium, Leptotrichia, Campylobacter, Prevotella) we dropped Streptophyta, 527 
Granulicatella, Oribacterium, Bulleidia and Prevotella. Similarly, from the intersected 528 
bacteria of figure 7 (Enhydrobacter, Methylobacterium, Catonella, Pseudomonas, 529 
Acinetobacter, Sphingomonas, Propionibacterium, Bulleidia) we dropped Bulleidia, 530 
Catonella, Sphingomonas and Enhydrobacter. For the graph representation, we used the 531 
color code already applied in the previous figures for the bacteria according to the 532 
taxonomic order. While for metabolites we classified them in 7 classes, assigning to each 533 
a different node shape and colour: vitamins, glycolysis, lipids, amino acids, carbohydrates, 534 
amines and miscellaneous. Furthermore, an enrichment analysis of metabolites (linked to 535 
the discriminative bacteria networks detected by PC-corr) has been conducted to unveil 536 
the metabolic pathways that might be associated to these bacteria perturbations. To this 537 
purpose, we used the framework provided by metaboloAnalyst suite 66. Specifically, we 538 
performed the “Enrichment Analysis” against the KEGG database and we selected the 539 
significant pathways according to the Benjianini corrected p-values smaller than the 540 
significance level of 0.05. For the case of the H. Pylori-affected network, just few nodes 541 
were available and only one significant pathway was obtained from it with few metabolite 542 
hits. Therefore, the network was expanded by adding first neighbours metabolites – 543 
obtained from KEGG – from the current ones. 544 
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Finally, the metabolite layer network nodes were grouped according to the three most 545 
significant pathways in both the PPI- and H. Pylori-affected bacteria-metabolite 546 
networks. This was ensured according to the following procedure: a ranking was 547 
generated for the list of significant pathways in each of the two networks. Then, the nodes 548 
of each network were grouped according to the three pathways with the highest average 549 
ranking in the two networks, which in our study are:  aminoacyl-tRNA biosynthesis; 550 
galactose metabolism; Alanine, aspartate and glutamate metabolism.  A fourth group 551 
encapsulating the metabolites involved in the other significant pathways was also 552 
provided. Regarding the links considered in each bacteria and metabolite layer, the 553 
bacteria-bacteria associations were maintained from figures 6 and 7, whilst edges between 554 
metabolites were obtained by the metabolite interaction involved in the significant 555 
enriched KEGG pathways.  556 
The processing pipeline has been developed in the R environment 67 and by using the 557 
following packages: igraph 68, taxize 69, graphite 70, RCy3 71. 558 
 559 
Computing platforms adopted to implement the algorithms  560 
Dimensionality reduction was performed in MATLAB on the abundance matrix of genus-level 561 
taxonomic assignments, with samples in rows and taxonomic assignments (OTUs) in columns. 562 
For MDSwUF, the computation of the weighted UniFrac distance was performed in R. We used 563 
the following MATLAB functions to calculate PCA, MDS and NMDS (Sammon Mapping) 564 
respectively: svd, cmdscale and mdscale. For the calculation of the Theta YC distance, the 565 
mothur 72 approach was implemented in MATLAB. For the calculation of Bray-Curtis 566 
dissimilarity, we used the function MATLAB f_braycurtis in the Fathom Toolbox 73 567 
(http://www.marine.usf.edu/user/djones/matlab/matlab.html). Instead, for the calculation of the 568 
weighted Unifrac distance for all sample pairs, we used the R function UniFrac in the phyloseq 569 
package (https://bioconductor.org/packages/release/bioc/html/phyloseq.html), after creating a 570 
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phyloseq-class object (with R function phyloseq in the same package) that contains both the 571 
abundance table (OTU table) and the phylogenetic tree. The MATLAB code for MCE/ncMCE 572 
is available online at: https://sites.google.com/site/carlovittoriocannistraci/5-datasets-and-573 
matlab-code/minimum-curvilinearity-ii-april-2012. For MCL clustering, we installed the 574 
MCL-edge software (http://micans.org/mcl/) in a Windows environment, following the 575 
procedure suggested by the authors in the software website. To apply this algorithm, we created 576 
a MATLAB function that generates automatically the input for MCL (equivalent to the 577 
mcxarray function in the software) and then uses a system call to run MCL in a UNIX-like 578 
environment (Cygwin, https://www.cygwin.com/). PC-corr method was performed in 579 
MATLAB on the abundance matrix of the genus-level taxonomic assignments, with samples in 580 
rows and taxonomic assignments in columns. The PC-corr algorithm is available as MATLAB 581 
function (as well as R function) at: https://github.com/biomedical-cybernetics/PC-corr_net. 582 
Then the obtained PC-corr and bacteria-metabolite networks were displayed by Cytoscape 583 
(http://www.cytoscape.org/). 584 
 585 
Results  586 
To answer the five questions stated in the Background section, we analysed the abovementioned 587 
16S rRNA gene sequencing datasets with information on PPI consumption in dyspeptic 588 
patients, following the flowchart shown in Fig. 1. Our study is innovative at two different 589 
levels. At the more general ‘methodological level’, we introduce a new computational data 590 
mining pipeline (Fig.1) which explains how to overcome the limits of current multivariate 591 
analysis of small-size microbial data. At the more specific ‘technical level’, we propose 592 
innovative solutions in each of the 5 steps that composes this pipeline: dimension 593 
reduction, clustering, PC-corr networks, multilayer bacteria-metabolite networks and 594 
metabolic network pathways analysis. In the dimension reduction section, we innovate by 595 
illustrating the benefits to apply minimum curvilinear nonlinear machine learning 596 
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methods for dimension reduction. This is a completely new technical way to perform 597 
nonlinear analysis in the microbial field. In the clustering section, we propose MC-MCL, 598 
which is the first nonlinear version of Markov clustering and represents a novel nonlinear 599 
clustering approach. In the PC-corr section, we show how to extract valuable and robust 600 
information (that would otherwise be missed using standard procedure of analysis) across 601 
several (4 in total) small-size microbial datasets. In the fourth and fifth step we clarify 602 
how to enhance the biomedical interpretation with the aim to increase the impact of the 603 
findings on the scientific community. 604 
It is important to underline that, in one of the three initially analysed datasets (in Paroni Sterbini 605 
et al.22), we have the additional information on positivity or negativity to H. pylori infection. A 606 
fourth dataset (Parsons et al. 32) is used only for the validation of the PC-corr network results 607 
and it contains not only information on PPI consumption but also additional information on 608 
positivity or negativity to H. pylori infection. 609 
Unsupervised approaches were chosen for dimension reduction, and clustering because 610 
supervised (constrained) methods have been shown to perform poorly on small datasets, as 611 
explained in the paper by Smialowski et al. 34 and the work by Zagar and colleagues 58. 612 
Firstly, we performed unsupervised dimension reduction, both linear and nonlinear (described 613 
in the ‘Methods- PCA, MDS (or PCoA) and LDA’ and ‘Methods- Minimum Curvilinear 614 
Embedding (MCE)’) and we focused on the first two dimensions of embedding as they are 615 
significantly related with the treatment/infection response (Suppl. Table S1). As we will 616 
show, linear techniques will fail to bring out the patterns in the microbial datasets, related to 617 
PPI-treatment. Instead, nonlinear dimension reduction will reveal the presence of hidden 618 
patterns related to PPI treatment. In particular, in the gastric biopsies dataset (Paroni Sterbini et 619 
al. 22), nonlinear dimension  reduction will point out the evidence of PPI perturbation. Secondly, 620 
clustering algorithms were applied to the studied datasets to confirm that the hidden patterns 621 
detected by nonlinear dimension reduction are well posed. Finally, the PC-corr algorithm 64 is 622 
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used to find the bacteria community (features) that make the difference between the patterns or 623 
groups, allowing our understanding of the PPI-induced and H. pylori-induced microbial 624 
perturbations. 625 
 626 
Gastric tissue dataset unsupervised analysis 627 
According to the questions formulated in our study, we are interested in an unsupervised 628 
approach to verify whether PPI drugs cause a major change in the gastric tissue microbiota of 629 
dyspeptic patients regardless of the initial pathological infection due to H. pylori 22.  630 
In our first analysis, we focused on the Paroni Sterbini et al. dataset 22 and, to facilitate the 631 
visualization of the sample separations in the 2D reduced space, we assigned: red colour to 632 
untreated dyspeptic patients without H. pylori infection (H-); green colour to untreated 633 
dyspeptic patients with H. pylori infection (H+); and blue colour to patients treated with PPI 634 
regardless of their H. pylori infection (P). However, to help to detect also the effect of the H. 635 
pylori infection we reported the labels close to each sample, with a ‘&H+’ indicating the 636 
infection (P&H+) or a ‘&H-’ indicating the absence of infection (P&H-). Finally, we also 637 
tested whether this separation into three main groups (H-, H+, P) is more truthful, from the 638 
metagenomics data standpoint, than the one in four groups (H-, H+, P&H-, P&H+). 639 
Figure 2 shows the results of the multivariate techniques widely employed in metagenomic 640 
studies, PCA (Fig. 2A), MDSbc (Fig. 2B), MDSwUF (Fig. 2C), and NMDS (with Sammon 641 
Mapping) (Fig. 2D) (for more detail see the corresponding method section; the plots represents 642 
the best results based on PSI-ROC in Suppl. Table S2), which could only differentiate the 643 
group of untreated H. pylori positive samples (green dots) with respect to the group of untreated 644 
H. pylori negative samples (red dots), and PPI treated samples (blue dots), and no further 645 
separation is significantly detectable. Considering the PSI results, the values are high (Table 646 
1 and Fig. 2) (evaluated in the 2D embedding space, for details see ‘Procedure to evaluate the 647 
performance of the dimension reduction algorithms’). PCA (PSI-ROC=0.85, PSI-PR=0.91) 648 
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and NMDS (PSI-ROC=0.85, PSI-PR=0.90) exhibit the highest PSI-ROC and PSI-PR 649 
values, followed by MDSwUF (PSI-ROC=0.84, PSI-PR=0.88) and MDSbc (PSI-650 
ROC=0.81, PSI-PR=0.86). Indeed, in all the plots there is a visible trend of separation between 651 
PPI-treated (blue dots) and untreated (red and green dots) samples, but this is not sufficient to 652 
declare the presence of the complete separation, and a manifest ‘crowding problem’ 33 mixes 653 
the two cohorts together (blue and red dots). According to this output, the dataset appears to be 654 
strongly influenced by the presence of H. pylori, which is the predominant taxon (abundance > 655 
50%, Suppl. Table S3, percent abundance sheet) in four of the untreated H. pylori positive 656 
patients: where H. pylori is predominant, sample groups are quite close to one another and far 657 
from all the other samples in all four multivariate analyses (Fig. 2). Thus, PCA and MDS mainly 658 
show us that these 16S rRNA amplicons separate according to H. pylori abundance, and there 659 
is no treatment-related pattern. 660 
Non-centred MCE (Figure 3A, DCS normalization) was the best performing technique, with a 661 
PSI-ROC of 0.91 and PSI-PR of 0.96 (Table 1) (for details see Suppl. Table S2). It even 662 
outperforms the nonlinear methods NMDS (Sammon Mapping) and MDSwUF, since MCE is 663 
automatically able to unsupervisedly infer from data the underlying (hierarchical) 664 
phylogenetic relationship among the bacteria. MCE does not receive in input any 665 
phylogenetic information but directly infers it from the bacterial abundance of the dataset 666 
by performing a hierarchical embedding, as already shown in the study of Alanis-Lobato et al. 667 
41 (see ‘Methods- MCE to unsupervisedly infer and visualize phylogenetic (hierarchical) 668 
relations’). The gain in performance compared with the rest of the dimensionality 669 
reduction techniques is relevant.  670 
Indeed, the PSI-ROC improvement from 0.85 (PCA and NMDS) to 0.91 is not trivial. We 671 
want to stress that in general offering an AUC-ROC result that is higher than 0.9 is 672 
considered relevant in all scientific literature. Furthermore, as suggested by Ammirati et 673 
al. 74, the same level of increase becomes more significant when being close to perfect 674 
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segregation. This becomes evident when “quantifying the improvement in terms of the 675 
distance from the exact predictor”. As a didactic example, let us compare the current PSI-676 
AUC improvement of 0.06 (0.85 – 0.91) against a case with a same hypothetical 677 
improvement but closer to randomness (0.50 – 0.56). In the former the relative 678 
improvement in respect to the exact predictor is 40% (computed as (0.91-0.85)/(1-679 
0.85)*100), whereas in the latter is 12% (computed as (0.56-0.50)/(1-0.50)*100). Similarly 680 
for PSI-PR, MCE (PSI-PR=0.96) relative improvement from PCA (PSI-PR=0.91) in 681 
respect to the perfect predictor is 56% (computed as (0.96-0.91)/(1-0.91)*100). 682 
Furthermore, the MCE performance does not depend on its centring/non-centring, in fact the 683 
centred MCE version resolves the nonlinearity in the data too. Whereas, PCA regardless of 684 
being centred or non-centred does not resolve the nonlinearity in the data. 685 
While MDS and PCA are confounded by the mixture of factors characterizing the samples and 686 
do not manage to resolve the differences between treated and untreated samples, non-centred 687 
MCE is the only technique that visibly separates samples by ordering them along the second 688 
dimension into three groups, detecting a treatment-related structure in the data (Fig. 3B). This 689 
is plausible, because in any non-centred embedding the first dimension points towards the 690 
centre of the manifold 33, while the second dimension in the case of non-centred MCE represents 691 
the direction of higher topological nonlinear extension of the manifold. Interestingly, untreated 692 
H. pylori negative samples (red dots, H-) gather in the upper tail of the samples’ distribution, 693 
while treated samples (blue dots, P), both H. pylori test positive (P&H+) and negative (P&H-694 
), are mixed and show no other internal discernible groups. Untreated H. pylori positive samples 695 
(green samples, H+) gather at the bottom of the plot (Fig. 3A). Unlike the other approaches, 696 
non-centred MCE detects a treatment-related structure in the data and separates patients into 697 
three, not four, groups: PPI-treated, untreated H. pylori negative and untreated H. pylori 698 
positive. This last group appears as a subgroup marginally discriminating from the PPI-treated 699 
group and the topology of the samples seems to suggest that PPI treatment modifies the gastric 700 
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microbiota of H. pylori-negative patients with dyspeptic symptoms and gastric mucosa 701 
inflammation, shifting their gastric ecosystem in the same direction of PPI-treated H. pylori-702 
positive patients. We speculate that the fact that PPI treatment and H. pylori infection determine 703 
the samples to gather in a similar position (i.e. out of the PPI-untreated/HP-negative group) in 704 
the non-centred MCE reduced space, indicates that both the PPI drugs and H. pylori induce an 705 
ecological change in the stomach, which might be driven by similar mechanisms. As a matter 706 
of fact, H. pylori can colonize the acidic lumen of the stomach thanks to its ability to hydrolyse 707 
urea into carbon dioxide (CO2) and ammonia (NH3) 
75, thus increasing the intragastric pH. On 708 
the other hand, PPIs obtain the same result through the inhibition of acid secretion in gastric 709 
parietal cells, which blocks H+/K+ -ATPases. Both processes are therefore shifting the gastric 710 
environment towards an alkaline condition. Thus, MCE provides an ordering of the groups 711 
along the second dimension that is related to pH increment (from H- to P&H+). Furthermore, 712 
we contrast MCE performance on this challenging dataset versus two baseline algorithms 713 
for nonlinear dimension reduction: t-SNE and Isomap. As we stressed in the introduction 714 
these algorithms require optimal tuning of parameters (two for t-SNE and one for 715 
Isomap). We believe that advanced nonlinear data analysis needs adaptiveness and 716 
automatization, whereas methods such as t-SNE and Isomap, although in principle are 717 
unsupervised, in practice are applied in a supervised manner and the hypothesized class 718 
labels are used to learn their best parameter tuning. Unlikely, in small size datasets, 719 
parameter tuning is a relevant issue that may cause overfitting, especially with more than 720 
one parameter such as in the case of t-SNE and, to the best of our knowledge, there is not 721 
yet any commonly accepted solution for this. Here, with the mere intention to provide a 722 
proof of concept that allows to compare MCE with other nonlinear dimension reduction 723 
methods, we apply a supervised procedure in which the labels are used to supervisedly 724 
tune the internal parameters of these methods and we select the solution which offers the 725 
best performance. The results are shown in Suppl. Figure S3. t-SNE (PSI-ROC: 0.90, PSI-726 
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PR: 0.94) and Isomap (PSI-ROC: 0.87, PSI-PR: 0.94) performances are lower than MCE 727 
performances, displaying difficulty to resolve the difference between treated and 728 
untreated samples, mostly for the cases of treated patients (blue points) and untreated 729 
patients without H. Pylori infection (red points). This indicates that in principle adaptive 730 
parameter-free algorithms such as MCE may also outperform more complex algorithms 731 
under difficult scenarios such as for this particular case. 732 
Similarly to the Paroni Sterbini et al. microbial dataset, the Tripartite-Swiss-roll dataset (that is 733 
a synthetic dataset containing nonlinear structures obtained by tri-partitioning a discrete Swiss-734 
Roll manifold 26 in a three-dimensional space, for more details see the Suppl. Methods section: 735 
Artificial Datasets), presents a hierarchical-organized nonlinearity (Fig. S1A). And also in this 736 
case, similarly to the result of the Paroni Sterbini et al. analysis, non-centred MCE is able to 737 
perform a hierarchical embedding that orders the hidden subgroups of the dataset along the 738 
second dimension of embedding (Fig. S1E). On the contrary - as already commented in the 739 
method section - PCA, MDSbc and NMDS (Fig. S1B-D) were unable to resolve the nonlinearity 740 
of the Tripartite-Swiss-Roll: its three partitions are either superimposed (Fig. S1B, D) or twisted 741 
in a horseshoe shape (Fig. S1C). Indeed, the Tripartite-Swiss-Roll is purposely created to 742 
reproduce a manifold that is nonlinear and discontinuous (broken in three parts) such as the 743 
results of MCE analysis of Paroni Sterbini et al. seems to be. Furthermore, to compare the 744 
different approaches in a more “realistic” scenario, a synthetic microbial-like dataset 745 
(which resamples the nonlinearities encountered in the Paroni Sterbini et al. data) is 746 
generated and analysed (for more details see the Suppl. Methods section: Artificial 747 
Datasets). MCE overcomes once again the other dimensionality reduction techniques and 748 
is very close to guarantee a separability equivalent to the one obtained in the high 749 
dimensional space (HD) (Suppl. Table S4). These results are similar to the ones obtained 750 
in the real datasets. As expected, MDS with weighted Unifrac distance is highly affected 751 
by the fact that phylogenetic information between synthetic features is not available and 752 
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it is directly extracted from the OTU table. Interestingly, and opposite to what already 753 
shown in the real dataset, MDS with Theta-YC distance obtains great performances close 754 
to MCE. 755 
For the Paroni Sterbini dataset, we also performed a supervised linear approach for dimension 756 
reduction, LDA (Suppl. Fig. S4), yet the cross-validation test showed that this constrained 757 
technique could re-assign samples to their groups with 54% of error (ldaCVErr in Suppl. Table 758 
S5), confirming its statistical invalidity for the small size dataset problem. 759 
Moreover, the clustering algorithms MCL and MC-MCL, that is the minimum curvilinear 760 
version of MCL were applied to the Paroni Sterbini et al. dataset and the best results (highest 761 
accuracies) are shown in Table 1 (bottom panel) (for more details see the methods’ sections 762 
‘From Markov Clustering (MCL) to Minimum Curvilinear Markov Clustering (MC-MCL)’ and 763 
‘Procedure to evaluate the performance of clustering algorithms’).  MC-MCL performs better 764 
than the MCL (both for three and four clusters), even if their accuracies are not remarkably 765 
high, confirming that difficulties in pattern-recognition arise also from the presence of three 766 
clusters in the high-dimensional space. In addition, the hypothesis of three clusters seems more 767 
congruous than four clusters, because both MC-MCL and MCL decrease their accuracies in 768 
detecting four clusters. 769 
While MC-MCL represents the minimum curvilinear version of MCL, MCE is the minimum 770 
curvilinear version of PCA, particularly valuable for small sample size datasets. The principle 771 
behind them is MC23, that suggests that curvilinear (nonlinear) distances between samples may 772 
be estimated as pairwise distances over their Minimum Spanning Tree (MST) (constructed 773 
according to a selected distance). In fact, as explained in 76, to approximate nonlinear 774 
(curvilinear) distances between the points of the manifold it is not necessary to reconstruct the 775 
nearest-neighbour graph. Indeed, a greedy routing process (that exploits a norm, for instance 776 
Euclidean) between the points in the multidimensional space is enough to efficiently navigate 777 
the hidden network that approximates the manifold in the multidimensional space. And a 778 
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preferable greedy routing strategy, at the basis of MC-kernel, is the minimum spanning tree 779 
(MST). 780 
Overall, we can conclude that both MCE in dimensionality reduction and MC-MCL in 781 
clustering perform better than the respective non-MC-based versions, and this result confirms 782 
the presence of nonlinear complexity in this dataset, generated by a three-body interaction 783 
(presence of three clusters). In addition, when considering correlation-based distances, they do 784 
not react to the presence of compositionality, since pairwise correlations are computed between 785 
samples. Compositionality instead is a problem that arises when the correlations is computed 786 
between OTUs (features) from metagenomics abundance data (which are normalized by diving 787 
each OTU count to the total sum of counts in the sample 77,78), which yields unreliable results 788 
due to dependency of microbial relative abundances. 789 
Moreover, because of the discovered major nonlinear complexity in the Paroni Sterbini gastric 790 
biopsy dataset, we wanted to verify whether it was generated by multi-grouping (three-body 791 
interaction problem associated to the presence of three hidden clusters). To do so, we applied 792 
PCA to three subsampled versions of the dataset (with the best normalization originally found 793 
for the complete dataset), each corresponding to the combination of two groups (Fig. 4A-C), 794 
and PCA could find significant separation (PSI-ROC and PSI-PR > 0.80). To further confirm 795 
that the presence of multiple sample groups generates the data complexity, we did the same for 796 
the Tripartite Swiss-Roll (Fig. S5A-C), where we recovered the discrimination, even though 797 
two comparisons overlap to some extent (Fig. S5A and C). Additionally, it might be argued 798 
that the presence of H. pylori only drives the difference of the microbial community, 799 
instead of PPI treatment. However, if this were the case, then the segregation between H+ 800 
and H- samples would be evident as well inside the PPI treated group. However, the P-801 
values are not anymore significant for this case (P-value PCA: 0.46 & P-value MCE: 1) 802 
and no evident segregation arises neither by eyes, as supported by the Suppl. Fig S6. 803 
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In conclusion, the results confirm that linear techniques, even if supervised like LDA, are not 804 
able to resolve the differences in the data due to the presence of nonlinear complexity generated 805 
by the three-body interaction (H-, H+ and P). Once the complexity is reduced to a two-body 806 
interaction, the problem tends to vanish and PCA can detect significant differences between the 807 
groups, as shown by the PCA pairwise comparisons.  808 
Hence, the results of unsupervised analysis on Paroni Sterbini et al. dataset show that PPI 809 
treatment causes a major change in gastric mucosal communities of dyspeptic patients, 810 
regardless of the initial pathological infection due to H. pylori. 811 
 812 
Comparison of unsupervised analysis in three gastro-esophageal datasets 813 
We compared the performance of unsupervised analysis (dimensional reduction and clustering) 814 
in the Paroni Sterbini dataset 22 (gastric biopsies) and two additional datasets by Amir and 815 
colleagues 21, that investigated the PPI influence on the esophageal microbiota (Amir3) and 816 
gastric fluid (Amir4).   817 
Table 1, top panel, shows the best results in performance of unsupervised dimension reduction 818 
(PCA, MDSwUF, MDSbc, NMDS, MCE, for details see ‘Methods - PCA, MDS (or PCoA) and 819 
LDA’ and ‘Methods - Minimum Curvilienar Embedding (MCE)’) according to PSI based on 820 
AUC and AUPR, on the three different datasets (for more details on the PSI see ‘Methods - 821 
Procedure to evaluate the performance of the dimension reduction algorithms’). Just the space 822 
of the first two dimensions of embedding were here used since they are the ones related 823 
with the treatment/infection –related structures (Suppl. Table S1).The mean performance 824 
across all datasets is shown in the last column of the table for each method. The corresponding 825 
ranked performance for each method, based PSI-ROC and PSI-PR, is presented instead in 826 
Table 2. For the Paroni Sterbini dataset, we show the results for three different labels (untreated 827 
H-, untreated H+ and PPI-treated). For the Amir datasets, the p-values were computed for two 828 
groups, identified by the presence or absence of PPI treatment. The PSI was also applied to the 829 
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data in the original high-dimensional (HD) space, as a reference to see how good the 830 
unsupervised dimension reduction approaches are in preserving the group separability in the 831 
HD. Moreover, the PSI-ROC and PSI-PR best results with trustworthiness and standard error 832 
on the real datasets, when applying leave-one-out-cross-validation (LOOCV), are shown in 833 
Suppl. Table S6.  834 
For the Paroni Sterbini dataset, the PSI evaluation in the first two dimensions of embedding 835 
identifies MCE as the best dimension reduction technique that is able to preserve the group 836 
separability in the HD space. Surprisingly, MCE (presented in Fig. 3A, PSI-ROC=0.91, PSI-837 
PR=0.96) outdoes HD in sample separation in three groups (for HD, PSI-ROC=0.88, PSI-838 
PR=0.94). Similarly, in Amir4, MCE (PSI-ROC=0.91, PSI-PR=0.920) succeeds in preserving 839 
the separability of the original HD space (in HD, PSI-ROC=0.98, PSI-PR=0.99), better than 840 
the other dimension reduction methods. Finally, dimension reduction analysis on the Amir3 841 
dataset shows that esophageal biopsies were significantly different before and after PPI 842 
treatment, as shown by MDSwUF results (PSI-ROC=1=PSI-PR), that surpass the PSI-ROC 843 
and PSI-PR values in HD space (PSI-ROC=0.95, PSI-PR=0.96). Markedly, MDSwUF 844 
reaches a value of AUPR and AUC of 1, meaning perfect classification of the samples. 845 
Overall, when averaging across all datasets, the two metrics based on PSI-ROC and PSI-PR 846 
pointed out that MDSwUF (PSI-ROC=0.90, PSI-PR=0.93) gave the best results of separability 847 
compared to HD (PSI-ROC=0.94, PSI-PR=0.96), followed by MCE with closer results (PSI-848 
ROC=0.90, PSI-PR=0.92). Then PCA is the third best result (PSI-ROC=0.87, PSI-PR=0.90), 849 
followed by MDStcy, NMDS and MDSbc. However, to conclude what is the best method, we 850 
considered an evaluation based on ranking (Table 2). It is important to note that MCE was the 851 
dimension reduction approach that ranked first in performance across all the datasets, followed 852 
by MDSwUF (Table 2). Hence, the results of sample separability suggest the presence of hidden 853 




Then clustering algorithms, MCL and its Minimum Curvilinear version (for more information 856 
see ‘Methods - From Markov Clustering (MCL) to Minimum Curvilinear Markov Clustering 857 
(MC-MCL)’), were used to confirm the well-possedeness of the hidden patterns that were 858 
recognized by nonlinear dimension reduction. The best results as highest accuracies in each 859 
dataset and the mean performance across all the datasets are exhibited in Table 1, bottom panel. 860 
As already discussed in the previous section, the minimum curvilinear version of MCL (MC-861 
MCL, acc=0.71) outperforms the MCL clustering algorithm (acc=0.67) in the Paroni Sterbini 862 
dataset, confirming the presence of underlying non-linear complexity in the data. However, the 863 
accuracy doesn’t reach high values, because of the difficulty in pattern recognition generated 864 
by the three-body problem in the HD space. Curiously, the accuracies for four clusters (H-, H+, 865 
P&H-, P&H+) drop to 0.58 for MC-MCL and to 0.63 for MCL, supporting the hypothesis that 866 
three clusters are more congruous than four clusters. Notably in Amir3, MC-MCL attains high 867 
clustering accuracy (acc=0.81), compared to MCL (acc=0.69). This is the dataset for which, 868 
surprisingly, Amir and collaborators did not find significant changes in the esophageal tissue 869 
microbiota following PPI-treatment, using classical MDS unsupervised multivariate method 870 
with unweighted UniFrac distance 21. Instead, in the gastric fluid dataset (Amir 4), MC-MCL 871 
and MCL got the same accuracy of 0.75, where a significant separation of samples according 872 
to PPI consumption was already proved in the original article 21.  873 
However, we have to clarify that normalizations besides scaling (DRS and DCS) and log-874 
transformation (log(1+x)) could potentially lead to different performance results of 875 
unsupervised analysis. Normalization is crucial to address uneven sampling depth and sparsity 876 
(high proportion of zeros) in microbiome data, like rarefying an OTU table, that is randomly 877 
sampling without replacement from each sample such that all samples have the same number 878 
of total counts (sequencing depth) 79–82 (http://qiime.org/scripts/single_rarefaction.html). This 879 
normalization is recommended to moderate the sensitivity of UniFrac distances to sequencing 880 
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(sampling) depth 52,83, especially differences in the presence of rare OTUs 50, nonetheless it is 881 
also considered statistically improper due to the omission of data 83. 882 
Another normalization was introduced in 2010 by Anders and colleagues for general sequence 883 
count data (function varianceStabilizingTransformation implemented in the Bioconductor 884 
DESeq2 package), that uses a Variance-Stabilization Transformation (VST) by modelling 885 
microbiome count data with Negative Binomial (NB) distribution 80,83. 886 
We also provide the results with these two different normalizations, and we further confirm that 887 
the data are segregated in the HD space when pre-processed according to them, as shown in the 888 
PSI-ROC and PSI-PR tables in Additional file (for negative binomial, Suppl. Tables S7-9; for 889 
rarefaction, Supplementary Table S12-14). Interestingly, across all the datasets MCE decreases 890 
its performance with these pre-processing techniques, remarkably with rarefied datasets, while 891 
the other linear techniques improve in performance (Suppl. Table S7 for negative binomial; 892 
Suppl. Table S12 for rarefaction), suggesting that these adjustments linearize the datasets. 893 
Indeed, since MCE is a hierarchical technique, it needs the presence of nonlinearity to perform 894 
well. In a similar way, with these two normalizations the accuracy of MC-MCL drops down 895 
(less remarkably in the rarefaction datasets), while the performance of MCL does not increment 896 
(Suppl. Table S10 for negative binomial; Supplementary Table S15 for rarefaction). It is true 897 
that some pre-processing steps such as negative binomial tend to linearize the data but, in this 898 
manner, they can also remove important nonlinear discriminative information, as we show with 899 
the results of unsupervised analysis. Therefore, some pre-processing approaches can also cancel 900 




Network analysis clarifies the effect of PPI-treatment on the gastric 903 
microbiota 904 
Five major phyla have been detected in the normal gastric microbiota: Firmicutes, 905 
Bacteroidetes and Actinobacteria dominate the gastric fluid samples, while Fusobacteria and 906 
Proteobacteria are the most abundant phyla in gastric mucosal samples 1. 907 
However, the composition and abundance of gastric microbiota may be affected by many 908 
factors, such as dietary habits, H. pylori infection, diseases and drugs, including PPIs 1. 909 
Yet, although recent studies have highlighted the potential of these antacid drugs to affect the 910 
gastric microbiota, more knowledge needs to be gained about the association between PPI usage 911 
and the non-H. pylori bacteria in the stomach. 912 
Since we wanted to investigate the effect of PPI intake on gastric microbiota in dyspepsia, we 913 
analysed: Amir4 for gastric fluid microbiota 21 and Paroni Sterbini et al. dataset 22 for gastric 914 
mucosal microflora, in the latter case restricting to PPI-treated H. pylori-negative (P&H-) and 915 
untreated H. pylori negative patients (H-). In both studies, the samples from dyspeptic patients 916 
were analysed using the same next-generation sequencing technologies for direct sequencing 917 
of 16S rRNA gene amplicons, 454 Pyrosequencing.  918 
For this purpose, we employed PC-corr algorithm, that was discussed in the Methods section 919 
named: ‘PC-corr network’.  In brief, PC-corr discloses the discriminative network of features 920 
that are associated to a sample separation along a principal component direction. Hence, we 921 
expect that the PC-corr network of bacteria will offer a view on how the community of 922 
bacteria respond to PPI-treatment perturbation in the gastric niche (environment), in 923 
dyspeptic patients. 924 
Up to this point, in order to assess the emergence of nonlinear patterns in data, the 925 
application and performance of linear and non-linear dimensionality reduction 926 
algorithms has been compared. Special focus was on Paroni Sterbini dataset, where the 927 
presence or absence of H. pylori infection in addition to the medical treatment (or not) 928 
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with PPI medicaments created a complex nonlinear scenario difficult to disentangle using 929 
linear transformations and even some nonlinear ones. Then, with the didactic help of the 930 
Tripartite-Swiss-roll dataset, we clarified that the origin of the Paroni Sterbini 931 
nonlinearity stays in the three-body problem. Indeed, considering pairwise comparisons 932 
of only two groups, the nonlinearity vanished. Based on these considerations, now we 933 
conduct only the two-group comparison of PPI treated/nontreated patients in which 934 
presence of H. Pylori was negative, since these data are available both in Paroni Sterbini 935 
and Amir. Such simplification of the investigation enables the application of the above 936 
mentioned PC-corr algorithm, since, for the binary class problem both Paroni Sterbini 937 
and Amir4 datasets present a significant segregation measured by MW-pvalue when 938 
embedded by the linear algorithm PCA. 939 
In Amir4 (gastric fluid), PCA revealed that gastric fluid samples were separated into two groups 940 
according to PPI treatment along PC2 and their difference is significant (p -value < 0.01) 941 
(Suppl. Figure S7). Hence, we built the PC-corr network 64 using the loadings of PC2 at cut-off 942 
0.5 (Suppl. Figure S8).  943 
Similarly for the Paroni Sterbini dataset (gastric mucosa), PCA (Suppl. Figure S9) could 944 
(significantly or close to significance) separate PPI-treated H. pylori-negative patients from 945 
untreated H. pylori-negative patients along PC2 and PC15 (p-value along PC2 = 0.014, p-value 946 
along PC15=0.054). Therefore we built the PC-corr network for both PC2 and PC15 947 
discriminating dimension using 0.5 cut-off (Suppl. Figure S10, panel A and B).  948 
Subsequently, to investigate how PPI is affecting the microbiota in the gastric environment, we 949 
considered the conserved PC-corr network as an indication of bacteria behavior robustness. 950 
It is obtained as the union of the two PC-corr networks (obtained for PC2 and PC15) derived 951 
from the Paroni Sterbini gastric mucosa dataset intersected with the PC-corr network derived 952 
from the Amir4 gastric fluid dataset. The resulting conserved network displays the bacteria with 953 
same trend in the two datasets, i.e. either increased or decreased abundance for patients with 954 
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PPI-treatment, respectively in red and black colour, as emphasized by the violet circle at the 955 
centre of Figure 5. Figure 6 is the same as Figure 5 but here the nodes are coloured according 956 
to phylum-level taxonomy. The conserved network which arises at the overlap between the two 957 
PC-corr networks (union of Paroni Sterbini networks intersected with the Amir4 network) is 958 
statistically significant (p-value=1.00e-04), as a result of the statistical test based on trying to 959 
obtain the same conserved network by random resampling the bacteria in the two networks 960 
(Suppl. Figure S11), implying the difficulty of generating this intersection simply at random 961 
(since this intersection lies to the right of the critical value at the 0.05 level in the distribution 962 
of overlap). This is an important result because it confirms the robustness of the detected 963 
conserved network as a microbiota signature perturbed by PPI treatment. The top and bottom 964 
panels in Figure 5 and 6 show instead the remaining part of Amir4’s network (top panel) and 965 
of Paroni Sterbini’s network (bottom panel) that are not in the intersection, and therefore might 966 
be more specific for the gastric fluid and mucosa respectively. The PPI-perturbed conserved 967 
network is characterized by a main interconnected module with nine bacteria of four different 968 
phyla (Bacteroidetes, Fusobacteria, Proteobacteria, Firmicutes) that are positively associated 969 
(red edges) and by two single bacteria order without interactions (Streptophyta, Clostridiales), 970 
all being increased following PPI treatment, except Streptophyta that is instead decreased with 971 
PPI-treatment (Fig. 5 and 6). Note that a mix between genera, phyla and order of bacteria can 972 
be found in the networks. The reason behind it is the availability of detail information regarding 973 
different bacteria. Some of the spotted bacteria (Veillonella, Clostridiales, Campylobacter) 974 
were already observed in previous studies. The genus Veillonella was found increased in 975 
relation to PPI use 16 in the gut microbiome and has been associated with increased 976 
susceptibility to Clostridium difficile infection 84.  These Gram-negative anaerobic cocci with 977 
lactate fermenting abilities are abundant in the human microbiome and are normally found in 978 
the intestines and oral mucosa of humans 85. Interestingly, they favour nitrite accumulation in 979 
the stomach during nitrate reduction, promoting a carcinogenic effect 1. In addition, the order 980 
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Clostridiales, that is associated to Clostridium difficile infection, was also seen significantly 981 
changed in the gastrointestinal tract, however Freedberg et al. 4 found it significantly decreased 982 
during PPI use, in contrast to our results. PPIs use also increases the risk of other enteric 983 
infections, apart from C. difficile infection, such as campylobacteriosis, as reported in 86,87. 984 
Moreover, half of the bacteria present in the network normally colonize the human oral 985 
cavity.  Indeed, it is the main purpose of PPI treatment to increase the stomach pH, and the 986 
higher pH of treated patients is known to favour the growth of bacteria that usually reside in 987 
the mouth and esophagus and are not adapted to survive the normal gastric acidity 6,20. 988 
Among genera usually reported as part of the normal microbiota of the gastrointestinal tract, 989 
only Veillonella is found regularly at other sites, like the mouth 88. Leptotrichia species mostly 990 
colonize the oral cavity  and they were isolated from various human infections, suggesting that 991 
they are emerging human pathogens 89,90. Oribacterium also inhabits the mouth, besides the 992 
upper respiratory tract 91. Prevotella is a genus of Gram-negative bacteria that tend to colonize 993 
the human gut, mouth and vagina, and may cause infections, mostly observed in the oral cavity 994 
(odontogenic infections) 90. Porphyromonas has been found by 92 as part of the salivary 995 
microbiome. Both Prevotella and Porphyromonas contribute to the formation of abscesses and 996 
soft tissue infections in various part of the body and they can cause infections, including 997 
periodontal and endodontal diseases 93. Capnocytophaga are inhabitants of the oral cavity too, 998 
and these opportunistic pathogens can cause infections (both in immunocompromised and 999 
immunocompetent hosts), the severity of which depend on the immune status of the host 94,95. 1000 
As well, Granulicatella are Gram-positive cocci normally found in the oral microbiota and are 1001 
uncommon causes of infections, nevertheless they can cause infections, including bloodstream 1002 
infection and infective endocarditis 96. Besides, the genus Fusobacterium inhabits the mucosal 1003 
membranes of humans and all its species are parasites of humans 97, and some species are found 1004 
in the oral cavity. The remaining bacteria (Campylobacter, Bulleidia) do not belong to the oral 1005 
microbiota 93. The genus Campylobacter was increased in relation to PPI use and the increased 1006 
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abundance of these Gram-negative bacteria has the potential to cause diseases and infections in 1007 
humans (most commonly diarrhoea). Due to the induced increase of pH, PPI is hypothesised to 1008 
facilitate gastrointestinal infections and a study by Brophy et al. 98 reported an increased risk of 1009 
Campylobacter infection following PPI therapy. Moreover Campylobacteriosis, mostly caused 1010 
by eating undercooked foods derived from poultry or other warm-blooded animals or contact 1011 
with contaminated water or ice 99, has been shown by the Dutch National Institute for Public 1012 
Health and the Environment to noticeably increase in incidence when PPI use grows 86.  1013 
Altogether, PC-corr approach was applied on gastric fluid and gastric mucosal datasets (in the 1014 
latter case, excluding the samples positive to H. pylori infection) to investigate how PPI is 1015 
affecting the gastric microbiota (both gastric fluid and gastric mucosal microbiota), because of 1016 
PC-corr’s ability to pinpoint the combination of bacteria that play a major role in the 1017 
discrimination of the samples, in this case according to PPI intake. The PC-corr conserved 1018 
network identified eleven genera and order of bacteria, which belong to the phyla 1019 
(Bacteroidetes, Fusobacteria, Proteobacteria, Firmicutes) commonly found in the stomach 1020 
which, with exception of Streptophyta, demonstrated increased abundance following PPI 1021 
treatment. Mostly all the found bacteria were not reported in previous studies, except 1022 
Veillonella, Clostridiales and Campylobacter, but they were found as inhabitants of the oral 1023 
cavity and/or possible cause of infections and diseases in humans. Hence, and in concordance 1024 
to previous studies 6,20, these results point out that PPI treatment, by increasing the intragastric 1025 
pH, favours the growth of bacteria that usually reside in the mouth and survive through the 1026 
harsh acidic conditions of the stomach. Furthermore, the results suggest that PPI-associated 1027 
increas of some bacterial populations may lead to infections and diseases or increase 1028 
susceptibility for other bacterial infections (like Veilonella) or promote a carcinogenic effect 1029 
(like Veilonella). Previous studies have highlighted that PPI intake is associated with decreased 1030 
bacterial richness 16,18,100,101, increased risk of enteric and other infections (e.g. caused by 1031 
Salmonella, Clostridium difficile, Shigella, Listeria) 17,102, increase in the abundance of oral and 1032 
41 
 
upper GI tract commensals and potential pathogenic bacteria  (e.g. Enterococcus, 1033 
Streptococcus, Staphylococcus, and Escherichia coli ) 16,17 in the gut microbiota. Nevertheless, 1034 
our analysis by means of PC-corr does not spot single bacteria perturbed in the gastric 1035 
environment by PPI treatment, but a community of bacteria is altered in abundance by PPIs and 1036 
their inter-specific bacterial interactions in the gastric niche. 1037 
Therefore our study will ground the basis for further investigations that could better clarify the 1038 
effect of PPI-treatment on the human gastric microbiota and additionally verify the identified 1039 
altered bacteria, as PPIs may have possible side-effects, including increased risks of different 1040 
infections and diseases.  1041 
 1042 
Network analysis clarifies the effect of H. pylori infection on gastric mucosal 1043 
microbiota 1044 
The stomach was long thought sparsely colonized by bacteria due to the gastric microbicidal 1045 
acidic barrier (pH<4.0) 103. This view dramatically changed with the discovery of the Gram-1046 
negative bacterium H. pylori in the 1980’s by Warren and Marshall 104, that is a carcinogenic 1047 
bacterial pathogen infecting the stomach of more than one-half of the world’s 1048 
human population. This human pathogen is able to survive in the highly acidic environment 1049 
within the stomach by producing cytoplasmic urease that, by catalysing the hydrolysis of urea 1050 
into CO2 and NH4, produces a  neutralizing ammonia cloud around it 
19,105,106. However, most 1051 
H. pylori avoid the acidic environment of the gastric lumen by swimming towards the mucosal 1052 
cell surface (using their polar flagella and chemotaxis mechanisms) and may adhere and invade 1053 
the gastric mucosal epithelial cells 107,108. Hence, it doesn’t represent a dominant species in 1054 
gastric fluid microbiota 109, but was found to generally to reside in the gastric mucosae 5,107,110.  1055 
Persistent (chronic) infection with this Gram-negative bacterium induces changes in gastric 1056 
physiology and immunology, e.g. reduced gastric acidity and parietal cell mass, perturbed 1057 
nutrient availability, local innate immune responses 111,112, that most probably induces shift in 1058 
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gastric microbiota composition 111. Although H. pylori colonization usually persists in the 1059 
human stomach for many decades without adverse effects, the infection of this bacteria is 1060 
associated with increased risk for several diseases, including peptic ulcers, chronic gastritis, 1061 
mucosa-associated lymphoid tissue lymphoma, gastric adenocarcinoma 113,114, and dyspepsia 1062 
115,116. The potential alterations induced by the H. pylori can in turn lead to dysbiosis and may 1063 
cause aberrant proinflammatory immune responses 117, susceptibility to bacterial pathogens and 1064 
increased risk of gastric disease, including cancer 1,118.  However, the effect of H. pylori 1065 
infection on overall composition of gastric microbiota at genus level and the bacterial interplay 1066 
in presence of this widespread human infection remain unclear.  1067 
Similar to the PPI treatment network analysis in the previous section, in order to 1068 
investigate the influence of H. pylori infection on the gastric mucosal microbiota by means 1069 
of PC-corr, we analysed: 1) Paroni Sterbini et al. 22 considering only PPI-untreated dyspeptic 1070 
patients, either infected (H+) or not by H. pylori (H-); 2) Parsons et al. 32 restricting to PPI-1071 
untreated patients from: i) normal stomach group with no evidence of H. pylori infection; ii) H. 1072 
pylori gastritis group with evidence of H. pylori infection. Even though the same technology is 1073 
important for a comparative study, unfortunately in the literature there was no such data 1074 
available like Paroni Sterbini’s one, that is 16S rRNA gene pyrosequencing data (derived from 1075 
gastric mucosal microflora in dyspeptic untreated patients either positive or negative for H. 1076 
pylori). Despite  this, the two studied datasets, obtained with two different next-generation 1077 
sequencing technologies for direct sequencing of 16S rRNA gene amplicons (454 1078 
Pyrosequencing for Paroni Sterbini et al. and Illumina MiSeq for Parsons et al.) 119, both contain 1079 
community profiling of gastric mucosa-associated microbiota in PPI-untreated H. pylori-1080 
negative and -positive subjects. However, for the sake of clarity, we have to specify a 1081 
difference: while in Paroni Sterbini’s dataset the gastric mucosal biopsy specimens were 1082 
collected from patients with dyspepsia, this is not the case for Parsons’s data.   1083 
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To enhance the understanding of the H. pylori-triggered microbial perturbation in this 1084 
ecological niche, we employed again PC-corr algorithm, that is able to associate to any PCA 1085 
analysis of an omic dataset, where a sample separation emerges, a network of discriminative 1086 
features (for details see ‘Methods-PC-corr network’). The analysis of the 16S rRNA sequencing 1087 
data was restricted only the overlapping OTUs, excluding Helicobacter because our goal is to 1088 
investigate its impact on the rest of the microbial network. 1089 
In Paroni Sterbini’s dataset, since PCA could significantly separate gastric mucosal biopsy 1090 
samples of PPI-untreated patients according to H. pylori-positivity (p-value=0.01) along PC2 1091 
(Suppl. Fig. S12), the PC-corr network was constructed from PC2 loadings at 0.5 cut-off (Suppl. 1092 
Fig. S13). Similarly, for Parsons’ dataset, since PCA (Supplementary Figure S14) could 1093 
significantly separate patients from the normal stomach group with no evidence of H. pylori 1094 
infection and PPI-untreated (Control) from H. pylori gastritis group positive to H. pylori 1095 
infection and not using PPIs (HPGas) along PC1 (p-value along PC1 <0.01,), the PC-corr 1096 
network was constructed from this discriminating dimension at 0.5 cut-off (Suppl. Fig. S15). 1097 
The obtained microbial differential networks (Figure 7, coloured according to phylum level) 1098 
pinpointed, from the system point of view, the bacteria affected by H. pylori infection in the 1099 
gastric mucosa, that are precisely bacteria whose abundance is decreased in H. pylori-positive 1100 
patients. A presumable explanation of this trend is already pointed out in literature, where the 1101 
presence of H. pylori leads to a reduced gastric microbial diversity 120–122. Nevertheless, in some 1102 
cases the diversity increases again, because of diverse factors that allow survival and 1103 
colonization of bacteria in the stomach 1,123. Then, the preserved network of gastric mucosa 1104 
microbiota was constructed by intersecting the two PC-corr networks obtained from Paroni 1105 
Sterbini’s and Parsons’s dataset. Figure 8, middle panel, shows the conserved network (violet 1106 
circle), which presents the common bacteria coloured according to phylum level and their 1107 
associations. The spotted bacteria display decreased abundance with H. pylori infection (i.e. 1108 
increased in H. pylori-negative subjects) in both the two 16S rRNA gene sequencing data. By 1109 
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performing a statistical test based on random resampling of the bacteria in the two networks, 1110 
we verified that the shown bacterial conserved network is statistically significant and difficult 1111 
to be generated at random (p-value=1.00e-04), because getting this intersection at random is 1112 
very rare (Supplementary Figure S16).  The top and bottom panels in Figure 8 show instead the 1113 
remaining part of Paroni Sterbini’s network (top panel) and of Parsons’s network (bottom 1114 
panel) that are not in the intersection. At the genus level, a study by Klymiuk et al. 124 identified 1115 
Actinomyces, Granulicatella, Veillonella, Fusobacterium, Neisseria, Helicobacter, 1116 
Streptococcus, and Prevotella as significantly different between the H. pylori-positive and H. 1117 
pylori-negative gastric samples. These bacteria do not emerge in the conserved network, while 1118 
they all (except Neisseria) appear altered (decreased) during H. pylori infection in the study by 1119 
Parsons and colleagues (present in the bottom panel of Figure 7). 1120 
Our analysis pinpoints a conserved network from two independent 16S rRNA gene sequencing 1121 
data, that reveals microbial communities altered by H. pylori infection and their interactions in 1122 
the gastric mucosa. It revealed a main core of six associated bacteria (with positive association, 1123 
red edges) and two single nodes without any interaction with the main module, from three 1124 
different phyla (Proteobacteria, Firmicutes, Actinobacteria) all resulting decreased in H. 1125 
pylori-infected subjects (that is increased in non-infected subjects). The decreased abundance 1126 
of the phyla Firmicutes and Actinobacteria in H. pylori-positive patients with respect to H. 1127 
pylori-negative subjects was already shown in a previous study by Maldonado-Contreras et al. 1128 
125. In addition, other studies have demonstrated an increased colonization of Proteobacteria in 1129 
H. pylori-positive patients 125,126, while the obtained conserved PC-corr network shows that the 1130 
bacteria from this phylum are instead decreased in those individuals. Among the spotted 1131 
bacteria, Methylobacterium is a genus of facultative methylotrophic bacteria that are commonly 1132 
found in diverse natural environments (such as leaf surfaces, soil, dust, and fresh water) and in 1133 
hospital environment due to contaminated tap water. Methylobacterium species can cause 1134 
health care-associated infections (mainly catheter infection), especially in 1135 
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immunocompromised patients 127. In addition, Sphingomonas plays a role in human health, as 1136 
some of the sphingomonads (in particular Sphingomonas paucimobilis) are the cause of a range 1137 
of mostly nosocomial, non-life-threatening infections. Sphinhomonas species are widely spread 1138 
in nature, having been isolated from many sources, from water habitats to clinical settings 128, 1139 
Pseudomonas, due to its great metabolic versatility, can also colonize different types of niches 1140 
129, including soil and water, in addition to plant and animal associations, and includes 1141 
pathogenic species in humans 130. Acinetobacter species are instead common, free-living 1142 
saprophytes found in soil, water, sewage and foods and are ubiquitous organisms in hospitals. 1143 
They have been increasingly identified as a key source of infection in debilitated patients in 1144 
hospitals, due to their rapid development of resistance to antimicrobials 131. In particular, one 1145 
species, Acinetobacter lwoffi, can trigger gastritis, apart from H. pylori 132. Propionibacterium, 1146 
so named for their unique ability to synthesize propionic acid by using unusual transcarboxylase 1147 
enzymes 133, are primarily facultative pathogens and commensals of humans, living on the skin, 1148 
while other members are widely employed for synthetizing  vitamin B12, tetrapyrrole 1149 
compounds, and propionic acid, as well as used as probiotics 134. Catonella is another node in 1150 
the network and this bacterial genus is obligative anaerobic, non-spore-forming and non-motile, 1151 
with one known species (Catonella morbi) from the human gingival crevice 135,136, that has been 1152 
associated with periodontitis 135 and endocarditis 137. Besides, the bacterial genus 1153 
Enhydrobacter so far contains a single species, Enhydrobacter aerosaccus, a Gram negative 1154 
non-motile bacterium that is both oxidase and catalase positive and shows gas vacuoles 138,139. 1155 
Bulleidia, a Gram-positive, non-spore-forming, anaerobic and non-motile genus,  has one 1156 
known species too (Bulleidia extructa)140.  1157 
In conclusion, by means of the PC-corr approach, we determined the combination of bacteria 1158 
responsible for the difference between H. pylori-positive and H. pylori-negative gastric mucosa 1159 
of untreated patients and their microbe-microbe interactions. All the bacteria, both in the 1160 
conserved network and not, were decreased in H. pylori-infected individuals (i.e. increased in 1161 
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H. pylori-negative group).  H. pylori, like acid suppressing medications (for the treatment of 1162 
dyspepsia), alters the population structure of the gastric and intestinal microbiota 141 and 1163 
regularly, this bacterium constitutes most of the gastric microbiota 123, literally depleting 1164 
bacterial biodiversity. Moreover, most of the identified bacteria represent bacteria of potential 1165 
health concern, as agents of diseases and infections.  1166 
Bacteria-metabolite multilayer network analysis associates possible 1167 
metabolic pathways perturbations 1168 
The relation between bacteria and metabolites is fundamental both to deepen the 1169 
understanding of mechanisms associated to diseases dysfunction and drugs action, and to 1170 
foster their biomedical interpretation 142–144.  For this reason, we made a quantum leap in 1171 
our investigation from bacteria to metabolites and we built two bacteria-metabolite 1172 
multilayer networks: one (Fig. 8) was derived from the PPI-affected bacteria network in 1173 
Fig. 6, the other (Fig. 9) was derived from the H. pylori-affected bacteria network in Fig.7. 1174 
The methodological procedure to build those multilayer networks is provided in the 1175 
Methods (see section: Bacteria-metabolite multilayer network construction). 1176 
Remarkably, by applying metabolic pathway enrichment analysis, we found that the 1177 
metabolite layer of the PPI-affected (Fig.8B) and H. pylori-affected (Fig.9B) networks 1178 
contain metabolites significantly involved (p<0.05 after Benjiamini correction) in 1179 
important pathways (see full list in Suppl. Tables S18 and S19) associated with obesity 145, 1180 
symptomatic atherosclerosis 146, functional dyspepsia 147, gestational diabetes mellitus 148 1181 
Wilson’s disease 149, among others. To simplify the visualization and interpretation (for 1182 
the methodology of selection see Method section: Bacteria-metabolite multilayer network 1183 
construction) we displayed the three most significant and relevant pathways in both PPI-1184 
affected (Fig.8B) and H. pylori-affected (Fig.9B) networks. Interestingly, the bacteria 1185 
Porphyromonas and Fusobacterium are highly contributing for possible perturbations on 1186 
the Aminoacyl-tRNA biosynthesis pathway for alterations produced by PPI (Figure 8B), 1187 
47 
 
whilst Methylobacterium does it on the H. Pylori infection side (Figure 9B). Besides, N-1188 
Acetylneuraminic acid (Suppl. Fig. S17) is a sialic acid that has been associated also with 1189 
pathogenic enteric bacteria 150,151 and tumors 152. Overproduction of nitrites and nitrates 1190 
by the observed anaerobic bacteria have been already observed in diverse parts of the 1191 
gastrointestinal tract in patients suffering from migraine 153, intestinal dysbiosis and 1192 
colorectal cancer 154,155, an effect already associated with the use of PPIs such as 1193 
omeoprazole 156.  1194 
Discussion 1195 
This study indicates the necessity of including nonlinear multidimensional techniques into 1196 
clinical studies based on 16S metagenomic sequencing data, since drawing a study’s 1197 
conclusions by solely relying on linear techniques, such as PCA and MDS, can lead to data 1198 
misinterpretation and impair the translational path from research to diagnostic. In the era of 1199 
post-genomics and systems approaches, nonlinear dimension reduction and clustering by MCE 1200 
and MC-MCL can offer new insights into complex clinical 16S metagenomics data, like the 1201 
ones studied in this article or the presence of clinical sub-types, and serve as a valuable tool in 1202 
the run towards precision medicine. Moreover, this study shows how it is possible to 1203 
complement multivariate analysis by means of network analysis employing PC-corr algorithm, 1204 
that accounts for the bacteria responsible for the sample discrimination and their co-occurrence 1205 
relationships. Precisely, from the system point of view the obtained microbial differential 1206 
networks pinpointed marked bacteria-bacteria interactions and modules affected by PPI 1207 
treatment in the gastric environment in dyspepsia and by H. pylori infection in the gastric 1208 
mucosa. Moreover, we elucidated via bacteria-metabolite multilayer networks, possible 1209 
metabolic alterations produced by the perturbed bacteria communities and the respective 1210 
metabolic pathways involved in those changes. The fact that we find significant metabolic 1211 
pathways associated to the discriminative bacteria networks, which are detected by PC-1212 
corr, is a nontrivial finding that suggests the reliability and impact of the integrated 1213 
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machine learning/network biology methodology we propose. However, some limitations 1214 
frequently present in integrative systems biology also affect our study. For instance, when 1215 
we adopt protein interaction networks in drug repositioning 157 or in disease analysis 158, 1216 
we are aware that further information such as the contextualization of the network to the 1217 
peculiar organ, tissue, cell or cell-compartment would allow more accurate results. The 1218 
same is valid for our study, where we have to adopt a generic bacteria-metabolite gut 1219 
network, because it is the most updated resource currently available in the field. This 1220 
means that when – hopefully in future - more specialized bacteria-metabolite networks 1221 
will be available for the gastric mucosa/fluid and even in specific areas of the stomach, 1222 
then our analysis - such as many other omic analysis in integrative network biology - will 1223 
benefit of this quantum leap in the data quality and contextualization. Hence, we suggest 1224 
that our findings can be an important starting point to design new therapies that consider not 1225 
only H. pylori infection but also the directly associated microbial alterations as well as the 1226 
indirect alterations due to the drugs used for H. pylori eradication such as PPI. 1227 
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Figure 1. Flowchart of the data analysis. To answer the five questions under investigation in our study, 1682 
we implemented a workflow based on machine learning tools. Following the flowchart shown in the 1683 
figure, we analysed three 16S rRNA gene sequencing datasets with information on PPI use in dyspeptic 1684 
patients; for one of the datasets (Paroni Sterbini et al. 22), patients were also determined to be positive 1685 
or negative to H. pylori infection. 1686 
Firstly, we performed unsupervised dimension reduction, both linear and nonlinear, in the first two 1687 
dimensions of embedding.  Nonlinear dimension reduction will show the presence of hidden patterns, 1688 
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in the form of sample groups. Secondly, nonlinear clustering was applied to confirm the well-1689 
possedeness of the hidden patterns found by nonlinear dimension reduction. Furthermore, our workflow 1690 
ends with the network analysis. It starts with the use of the PC-corr algorithm, that reveals which 1691 
combination of bacteria (features) are responsible for the identified differences between the groups of 1692 
samples. A fourth dataset (Parsons et al 32.) is used only for the validation of the PC-corr network results 1693 
and it contains information of PPI treatment and H. pylori infection. From the consensus bacteria found 1694 
in each PC-corr network, a bacteria-metabolite multilayer analysis that lastly end with the metabolite 1695 




Figure 2. Dimension reduction techniques usually employed in metagenomic data analysis and 1698 
applied to the Paroni Sterbini dataset. The plots represent the best PCA and MDS results based on 1699 
(average) p-value projection-based separability index (PSI) for the three different labels (PPI-treated, 1700 
untreated H+ and untreated H-), evaluated in the 2D embedding space. Moreover, also the average 1701 
values of all pairwise PSI-ROC and PSI-PR are reported as overall estimators of separation between the 1702 
groups in the 2D reduced space. (A) PCA; (B) MDS with Bray-Curtis dissimilarity (MDSbc); (C) MDS 1703 
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with weighted UniFrac distance (MDSwUF); (D) non-metric MDS with Sammon Mapping (NMDS). 1704 
Blue dots represent PPI-treated samples, while red and green dots are the untreated samples which 1705 
resulted either negative (red) or positive (green) to the H. pylori test (histological observation and urease 1706 
test). 1707 
 
Figure 3. MCE, a topological machine learning for nonlinear and hierarchical dimension 1708 
reduction. A) Results on the Paroni Sterbini et al.22 dataset. The shown best MCE result is based on 1709 
PSI-PR projection-based separability index (PSI) for the three different labels (P-treated, untreated H+ 1710 
and untreated H-), evaluated in the 2D embedding space under the DCS normalization. The PSI-ROC 1711 
and PSI-PR are reported as overall estimators of separation between the groups in the 2D reduced space. 1712 
Blue dots represent PPI-treated samples, while red and green dots are the untreated samples which 1713 
resulted either negative (red) or positive (green) to the H. pylori test (histological observation and urease 1714 
test). B) The curves in three different colours (red, blue and green) highlight the different distributions 1715 












Table 1. Results of unsupervised analysis on the real datasets. Best results of unsupervised 
dimension reduction techniques (top panel) and of clustering (bottom panel).  
(Top panel): Best results of unsupervised dimension reduction techniques according to the PSI indices 
for sample separation in the space of the first two dimensions of embedding. HD (no dimension 
reduction) represents the reference results to see how good the separability present in the high 
dimensional space is preserved by dimension reduction techniques. Results are ordered from the best 
(top) to the worst (bottom) method. For the Paroni Sterbini dataset, we show the results for three 
different labels (PPI-treated, untreated H+ and untreated H-). For the Amir datasets, the PSI measures 
were computed for two groups, identified by the presence or absence of PPI treatment. For each PSI 
value, a respective trustworthiness was calculated. 
(Bottom panel): Best results of clustering (highest accuracies, regardless of the normalization and type 
of correlation) MCL and MC-MCL, in each of the three studied datasets (Paroni Sterbini, Amir3 and 
Amir4), and the mean performance (mean of the highest accuracies) across all the datasets.  
For Paroni Sterbini dataset, we show the results for three clusters (PPI-treated, untreated H+ and 
untreated H-) and in brackets the results for four clusters (P&H+, P&H-, untreated H+ and untreated 
H-). Instead, for Amir datasets, the accuracies were computed for two groups, identified according to 
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the presence or absence of PPI treatment.
 
Note:  all PSI-ROC and PSI-PR values can be found in Supplementary Table S2, while all the 
accuracies can be found in Supplementary Table S17. 
Abbreviations: HD: High Dimension; MCE: Minimum Curvilinear Embedding; MDSbc: 
Multidimensional Scaling with Bray-Curtis dissimilarity; MDSwUF: Multidimensional Scaling with 
weighted UniFrac distance; NMDS: Non-metric Multidimensional Scaling; MDStyc: Multidimensional 
Scaling with Theta-YC distance; PCA: Principal Component Analysis; MCL: Markov Clustering; MC-
MCL: Minimum Curvilinear Markov Clustering; PSI-ROC: Projection Separability Index measured by 
Area Under the Curve; PSI-PR: Projection Separability Index measured by Area Under the Precision 








Figure 4. Pairwise PCA of Paroni Sterbini’s gastric samples. PCA was applied to three subsampled 
versions of the Paroni Sterbini dataset (keeping the best normalization found for the original dataset), 
each corresponding to the combination of two groups: (A) PPI-treated and untreated H. pylori negative 
samples; (B) PPI-treated and untreated H. pylori positive samples; (C) untreated H. pylori negative and 
untreated H. pylori positive samples. The PSI-ROC and PSI-PR are reported as well as overall estimators 
of separation between the groups in the 2D reduced space. 
 
Table 2. Ranked performance of unsupervised dimension reduction techniques on the real 
datasets. The table shows the ranked performance of unsupervised dimension reduction techniques 
according to the PSI indices for sample separation (PSI-ROC and PSI-PR) in the space of the first two 
dimensions of embedding, for the three studied datasets (Paroni Sterbini, Amir3 and Amir4). Each rank 
is related to the results obtained in Table 1, top panel. The results are ordered by the mean performance 
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(fourth column) from the best (top) to the worst (bottom) method.
 
Abbreviations: HD: High Dimension; MCE: Minimum Curvilinear Embedding; MDSbc: 
Multidimensional Scaling with Bray-Curtis dissimilarity; MDSwUF: Multidimensional Scaling with 
weighted UniFrac distance; NMDS: Non-metric Multidimensional Scaling; MDStyc: Multidimensional 
Scaling with Theta-YC distance; PCA: Principal Component Analysis; PSI-ROC: Projection 
Separability Index measured by Area Under the Curve; PSI-PR: Projection Separability Index measured 




Figure 5. PC-corr method to unveil how PPI is affecting the microbiota in gastric environment in 1717 
dyspeptic patients. (Middle panel) To investigate the effect of PPIs on the gastric microbiota in 1718 
dyspeptic patients, we constructed the conserved PC-corr network at 0.5 cut-off, by merging the PC-1719 
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corr networks obtained from the gastric mucosa (Paroni Sterbini et al. 22) and the gastric fluid (Amir et 1720 
al. 21). To do so, we firstly considered the union of the two PC-corr networks obtained from the gastric 1721 
tissue dataset and then we intersected it with the PC-corr network from the gastric fluid dataset. All the 1722 
bacteria spotted in the conserved PC-corr network (violet circle) were found increased with PPI use.  In 1723 
both the two studied datasets, red nodes indicate bacteria whose abundance is increased with PPI-1724 
treatment, while black nodes indicate bacteria with lower abundance following treatment with this acid 1725 
suppressing medication. The common bacteria that showed an opposite trend in the two datasets, i.e. 1726 
microbial abundance increased in one dataset and decreased in the other dataset, were removed from the 1727 
network. (Top panel) The top panel shows the obtained Amir4’s network, not in common with the 1728 
Paroni Sterbini’s network. The module on the left side (except Enterobacteriaceae) include bacteria 1729 
more abundant following PPI-treatment in Amir4’s data, while the module on the right (and 1730 
Enterobacteriacea) is composed of decreased bacteria in abundance under PPI therapy in Amir4’s data.  1731 
(Bottom panel) The bottom panel represents the part of Paroni Sterbini’s network (union of the two 1732 
PC-corr network), that is not shared with Amir4’s one. As in the top and middle panels, the colour of 1733 
the nodes represents if the bacteria display higher (red nodes) or lower abundance (black nodes) in PPI-1734 





Figure 6. PC-corr networks to unveil how PPI is affecting the microbiota in gastric environment 1736 
in dyspeptic patients, coloured according to phylum-level taxonomy. To investigate the effect of 1737 
PPIs on the gastric microbiota in dyspeptic patients, we constructed the conserved PC-corr network at 1738 
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0.5 cut-off, by merging the PC-corr networks obtained from the gastric mucosa (Paroni Sterbini et al. 1739 
22) and the gastric fluid (Amir et al. 21). To do so, we firstly considered the union of the two PC-corr 1740 
networks obtained from the gastric tissue dataset and then we intersected it with the PC-corr network 1741 
from the gastric fluid dataset. All the bacteria spotted in the conserved PC-corr network (violet circle) 1742 
were found increased with PPI use. (Top panel) The top panel shows the obtained Amir4’s network, 1743 
not in common with the Paroni Sterbini’s network. The module on the left side (except 1744 
Enterobacteriaceae) include bacteria more abundant following PPI-treatment in Amir4’s data, while the 1745 
module on the right (and Enterobacteriacea) is composed of decreased bacteria in abundance under PPI 1746 
therapy in Amir4’s data.  (Bottom panel) The bottom panel represents the part of Paroni Sterbini’s 1747 
network (union of the two PC-corr network), that is not shared with Amir4’s one. As in the top and 1748 




Figure 7. PC-corr network to investigate the effect of H. pylori infection on the gastric mucosal 1751 
microbiota, coloured according to phylum-level taxonomy. (Middle panel) To investigate the effect 1752 
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of H. pylori infection on the gastric mucosal microbiota, we constructed the conserved PC-corr network 1753 
at 0.5 cut-off, by intersecting the PC-corr networks obtained from Paroni Sterbini et al. 22 and Parsons 1754 
et al 32 dataset. All the bacteria spotted in the conserved PC-corr network (violet circle) were found 1755 
decreased in abundance with H. pylori infection.  The common bacteria that showed an opposite trend 1756 
in the two datasets, i.e. microbial abundance increased in one dataset and decreased in the other dataset, 1757 
were removed from the network. (Top panel) The top panel show the obtained Paroni Sterbini’s 1758 
network, not in common with the Parsons’s network. It contains all bacteria whose abundance is 1759 
decreased in H. pylori-positive patients in Paroni Sterbini et al. dataset. (Bottom panel) The bottom 1760 
panel represent the part of Parsons’s network that is not shared with Paroni Sterbini’s one. As in the top 1761 
and middle panels, it includes bacterial communities decreased in H. pylori-infected patients. 1762 
 1763 
 1764 
Figure 8. PPI-affected bacteria-metabolite network in gastric environment of dyspeptic patients. 1765 
(A) Multilayer (bacteria-metabolite) network representation: the first layer is derived from Fig.6 and 1766 
represents the consensus network (confirmed in two datasets: gastric mucosa from Paroni Sterbini et al. 1767 
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22 and gastric fluid from Amir et al. 21) with PPI-affected bacteria nodes that present information on 1768 
metabolite interaction in 65. The second layer represents the network whose nodes are the metabolites in 1769 
65 interacting with the bacteria network in the first layer; different node shapes and colours refer to 1770 
different metabolite classes (carbohydrates, amino acids, glycolysis, amines, miscellaneous). (B) In 1771 
depth visualization of the bacteria-metabolite network interactions. The metabolites are grouped 1772 
according to their involvement in significant pathways. For discernibility, the metabolites are arranged 1773 
according to three significant pathways (p < 0.05 after Benjamini correction as result of a metabolite 1774 
pathway enrichment analysis) and a fourth group that encloses altogether nodes associated to other 1775 
significant pathways (please refer to the method section: Bacteria-metabolite multilayer network 1776 
construction and metabolite pathway analysis); note that only metabolites present in significant 1777 
pathways are here displayed. For more information, please refer to figure S17 and table S18. The 1778 
bacteria node stroke color is associated to the phyla information as in Figure 6, whereas the different 1779 
colours in the inner fill are associated to the different pathways and their extent is proportional to the 1780 





Figure 9. H. pylori-affected bacteria-metabolite network in gastric environment of dyspeptic 1784 
patients. (A) Multilayer (bacteria-metabolite) network representation: the first layer is derived from 1785 
Fig.7 and represents the consensus network (confirmed in two different datasets of gastric mucosa: 1786 
Paroni Sterbini et al. 22 and Parsons et al. 32) with H. pylori-affected bacteria nodes that present 1787 
information on metabolite interaction in 65. The second layer represents the network whose nodes are 1788 
the metabolites in 65 interacting with the bacteria network in the first layer; different node shapes and 1789 
colours refer to different metabolite classes (carbohydrates, amino acids, glycolysis, lipids, vitamins, 1790 
miscellaneous). (B) In depth visualization of the bacteria-metabolite network interactions. The 1791 
metabolites are grouped according to their involvement in significant pathways. For discernibility, the 1792 
metabolites are arranged according to three significant pathways (p < 0.05 after Benjamini correction as 1793 
result of a metabolite pathway enrichment analysis) and a fourth group that encloses altogether nodes 1794 
associated to other significant pathways (please refer to the method section: Bacteria-metabolite 1795 
multilayer network construction and metabolite pathway analysis); note that only metabolites present in 1796 
significant pathways are here displayed. For more information, please refer to figure S18 and table S19. 1797 
The bacteria node stroke color is associated to the phyla information as in Figure 7, whereas the different 1798 
colours in the inner fill are associated to the different pathways and their extent is proportional to the 1799 
number of metabolites that the bacterium connects with in the different displayed pathways.       1800 
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